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ABSTRACT 
 
α-Synuclein (AS) fibrils are the main component of Lewy bodies, filamentous inclusions 
known as the pathological hallmark of Parkinson’s disease (PD). The normal function, toxic state 
and detailed fibrillation pathway of AS are not well understood. However, AS is further 
implicated in PD by the presence of three single point mutations—A53T, A30P and E46K—and 
allele duplication or triplication in the familial form. One unifying difference between the single 
point mutations is their relative fibrillation rates; while E46K and A53T fibrillate more quickly, 
A30P fibrillates more slowly relative to the wild-type. Other factors that dictate the fibrillation 
rate of AS include: protein and salt concentration, agitation, temperature and pH. Therefore, 
carefully controlling fibrillation conditions is essential for making fair comparisons between 
wild-type AS fibrils and any sequential or environmental manipulations. This allows for the 
distinction between significant perturbations and slight differences from one sample batch to the 
next. Environmental manipulations of interest include: (1) the addition of metals and (2) a 
decrease of pH. Although there is no direct evidence linking metals to neurodegenerative 
diseases, evidence of elevated levels of metals are found in healthy aging brain and in brain of 
patients with neurodegenerative diseases. In addition, mitochondrial deficiencies and oxidative 
stress caused by cytosolic acidification have been associated with several PD cases. Several 
efforts have been made to identify the effects of these sequential and environmental 
manipulations; however, the techniques used were of low resolution or poor quality. Here, we 
have used the well-established, high-resolution methodologies of solid-state NMR to investigate 
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the anomalies and differences between standard wild-type AS fibrils and those that have been 
sequentially or environmentally manipulated. 
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CHAPTER 1 
INTRODUCTION 
 
1.1  Connection between α-synuclein and neurodegenerative diseases 
Parkinson’s disease (PD), multiple system atrophy and many other neurodegenerative 
diseases have similar pathologies that manifest as filamentous inclusions termed Lewy bodies 
(Figure 1.1) (1). The principal proteinaceous component of Lewy bodies is aggregated α-
synuclein (AS), a 140 amino acid protein arranged in an unknown fibrillar structure (2). The 
normal functions of AS are also unknown, but AS shares conserved features with the 
exchangeable apolipoproteins (3); in addition, several lines of evidence suggest a role for AS in 
presynaptic vesicle trafficking (4-6). The toxic state of AS, whether the protofibrils or the mature 
fibrils, and how this fibrillation mechanism relates to PD is an ongoing debate (7-11). The 
detailed mechanism of how AS fibrils assemble from monomers through protofibrils to mature 
fibrils is also poorly understood (Figure 1.1) (12). Investigating the structure of AS fibrils and 
the effect of sequential and environmental manipulations on the structure in great detail may 
further illuminate its role in PD pathology. In addition, this knowledge will lead to rational 
development of diagnostics and therapies for PD. 
1.2  Propensity to self-associate 
Several sequential characteristics are predicted to influence fibril formation. One of these 
characteristics includes the appearance of consecutive amino acids containing hydrophobic side-
chains. Evidence of this was shown to increase aggregation upon mutating to more hydrophobic 
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amino acids of nucleation sites (13-15). Correspondingly, mutating to hydrophilic amino acids 
decreases the rate of aggregation. The region believed to be essential for the aggregation in AS is 
said to be 71-82 (16). This stretch is located inside the proposed fibril core 30-98 (17-20) and is 
also a part of the sixth characteristic KTKEGV imperfect repeat found in AS (Figure 1.2). AS 
contains seven of these KTKEGV imperfect repeats and after mutation of the sixth repeat 
(69AVVTG74V to KTKEGV), the rate of fibrillation decreases (21, 22). Finally, AS possesses a 
highly negatively charged C-terminus (Figure 1.2), which upon neutralization or truncation 
increases the rate of AS fibrillation (23, 24). Similarly, in other aggregation systems, a high net 
charge inhibits the propensity to aggregate (14, 25). Analogously, the C-terminus of AS is 
proposed to inhibit aggregation by long-range electrostatic interactions between itself, the N-
terminus and the fibril core (26-28). Furthermore, mutations, A30P and A53T are reported to 
disrupt these long-range interactions (29). However, in a separate investigation by solution 
NMR, the mutant E46K increases the affinity of this interaction, while mutants A30P and A53T 
have no effect (30). Initial structural studies of AS fibrils support the existence of a central β-
sheet core, but did not provide detailed information on the extent of the structured regions nor 
the topology (7, 31). Further investigation into the long-rang interactions and the wild-type (WT) 
structure will provide a fundamental understanding regarding the mechanism of AS fibrillation. 
The recent chemical shift assignments reported for full-length WT AS fibrils (32) is the first step 
in solving the high-resolution structure of WT AS fibrils. 
1.3  Early onset Parkinson’s disease mutants 
While PD is typically sporadic, several mutations in the SNCA gene encoding AS are 
associated with familial PD, including single point mutations—A53T (33), A30P (34) and E46K 
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(35)—and allele duplication (36) or triplication (37). Although the PD-associated AS mutations 
are extremely rare, analysis of their pathogenicity could significantly illuminate the mechanisms 
underlying sporadic disease. Like the wild-type (WT) protein expressed in E. coli, all mutant 
forms of AS are intrinsically unfolded in aqueous solution, but adopt an α-helical secondary 
structure within their N-termini upon binding to phospholipid vesicles or detergent micelles (38, 
39). Within A30P, the helical domain is partially disrupted by proline substitution, with a 
consequential decrease in lipid affinity (38), while the A53T and E46K mutants exhibit similar 
or enhanced lipid binding when compared to WT AS (38, 40). Thus, altered lipid affinity is not a 
unifying phenotype for disease-associated mutants. 
While each of the three point mutations A53T (33), A30P(34) and E46K (35) cause early 
onset PD (Figure 1.1), each mutant has different properties related to fibrillation kinetics and 
fibril structure. A53T exhibits a faster fibrillation rate (40-44) and promotes more oligomeric 
species (42, 45, 46). In addition, A30P promotes more oligomeric species (42, 45, 46) and 
overall aggregation (47) and has a slower fibrillation rate relative to the WT (41). Conversely, 
E46K has a shorter lag phase, which increases the fibrillation rate (40-44). However, E46K does 
not promote the oligomeric species (30). On the other hand, A30P AS has been reported to 
fibrillate more slowly than WT AS in vitro (42) and to preferentially populate a soluble, 
protofibrillar intermediate, whereas WT readily progresses to mature, insoluble fibrils (46). This 
has fueled speculation that the mechanism of A30P toxicity may be fundamentally different than 
WT AS. Only recently has tissue from a familial PD patient with the A30P mutation become 
available for analysis. This individual displayed neuropathology typical of idiopathic PD, but 
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with a greater-than-typical load of insoluble fibrillar aggregates (48). This is a surprising result 
that strongly implicates fibrillar AS in the pathogenesis of A30P-dependent PD.  
Although the A30 and E46 positions are conserved across a variety of species, the A53 
position is not. A threonine is present instead of an alanine at position 53 for non-primate 
mammals along with six other substitutions: S87N, L100M, N103G, A107Y, D1221G and 
N122S (33). Elevated neurodegenerative effects are displayed in mice expressing human A53T 
AS (49-55); this suggests that these additional substitutions may add a complementary 
physiological effect to A53T. Similarly, mice expressing human E46K AS form inclusions 
closely resembling those of human Lewy bodies (56). These results further support the 
relationship between AS fibrils and PD pathology. 
Regardless of their relative fibrillation rates (7, 46, 57), the mutants and WT AS fibrils have 
similar morphologies when viewed by low resolution techniques, such as electron microscopy 
(58). Heise et al. also reported an extended β-sheet core in A53T AS fibrils (59). However, this 
study reported problems in reproducing samples that yielded different fibril polymorphs between 
different batches of WT sample preparations (18, 59). Therefore, the irreproducible sample 
preparations make it difficult to obtain an accurate structural comparison between the WT and 
A53T mutant. Recent solution NMR studies of quenched hydrogen/deuterium (H/D) exchange 
have suggested that the A30P mutation does not perturb the location or arrangement of β-strands 
in WT AS fibrils (60). However, it is not possible to draw site-specific conclusions regarding the 
structure from H/D exchange experiments alone; for example, some β-sheet regions may be 
more exposed than others or protected regions may not exhibit a β-sheet secondary structure. In 
addition, these indirect measurements rely on low molecular weight samples, which require 
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fibrils to be broken down into smaller units because of their high molecular weight. Therefore, it 
is essential to achieve reproducible fibrils preparations in the solid-state in order to investigate 
the anomalies and differences between the PD-related mutants and WT fibrils. 
1.4  Significance of low pH fibrils 
Mitochondrial deficiencies (61-63) and oxidative stress caused by cytosolic acidification 
have been associated with several PD cases (64). In addition, lowering pH causes the rate of AS 
fibrillation to increase (65, 66). The accelerated fibrillation rate may be caused by a 
neutralization of the highly negatively charged C-terminus of AS (Figure 1.2), (23, 24). This is 
consistent with other aggregation systems where a high net charge inhibits the propensity of 
aggregation (14, 25). However, there has yet to be a detailed investigation to validate this 
hypothesis. The isolation of differences between physiological and low pH AS fibrils will 
provide insight into the driving force of fibril stability.  
1.5  Metal-binding association to α-synuclein 
Although there is no direct evidence linking metals to neurodegenerative diseases, evidence 
of elevated levels of metals, such as Fe+3 (67, 68), Zn+2 (69) and Cu+2 (70), are found in healthy 
aging brain and in brain of patients with neurodegenerative diseases (71). In addition, the rate of 
AS fibrillation increases in the presence of certain metal ions, such as Cu+2 and Fe+3 (72, 73). In 
particular, Cu+2 has a significantly high binding affinity to AS (73). It is proposed that the 
induction of nucleation by various metals, including Cu+2, has the effect of neutralizing the 
repulsion of negatively charged amino acids primarily found in the C-terminus, which causes the 
unstructured protein to collapse (72, 74). However, a truncation of the C-terminus showed high 
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affinity Cu+2 binding in the N-terminus (residues 3-9 and 49-52, containing H50) in solution 
(73). Further evidence has indicated that each Cu+2 binding-site is independent with no effect on 
Cu+2 binding affinity upon mutation of residue 50 from His to Ala (75). Currently, bound and 
unbound AS monomer to Cu+2 is established to have similar structures through electron 
paramagnetic resonance, circular dichroism and solution NMR (72, 76). Conversely, the fibril 
form of AS was observed to be macroscopically different in the presence of metals, as observed 
by transmission electron microscopy and far-UV circular dichroism (72, 77). Nevertheless, these 
techniques lack the ability to evaluate site-specific structural differences between AS fibrils 
bound and unbound to Cu+2. Identifying the region where metals cause conformational changes 
to the fibril structure may help reveal the role metals play in neurodegenerative diseases, such as 
PD.  
1.6  Magic-angle spinning solid-state NMR 
Protein fibrils, such as AS, are insoluble, which precludes formation of high quality crystals. 
Hence, commonly used structure determination techniques cannot be used to obtain atomic level 
structure information of these systems. However, magic-angle spinning (78, 79 ) solid-state 
NMR (SSNMR) (80-90) is a well-established technique for investigating the structure, dynamics 
and function of a wide variety of biological systems, regardless of molecular weight, solubility 
and ability to form crystals without altering sample integrity. The SSNMR community has made 
significant progress in the study and understanding of amyloid fibrils (91, 92), such as β2-
microglobin (93, 94), Het-s(218-298) (95-100) and Transthyretin(105-115) (101, 102). There are 
SSNMR methods established to study protein-protein interactions through chemical shift 
perturbations (103), as well as to investigate structure-based drug design (103-106) and 
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interactions between proteins and a membrane surface (107, 108). These advances and the 
current progress in the Rienstra group towards solving the structure of WT AS by SSNMR (32, 
89, 109, 110) has helped systematically identify site-specific changes in secondary structure 
upon sequential and environmental manipulations of AS fibrils. 
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1.8  Figures 
 
  
 
Figure 1.1  General schematic of fibril formation of amyloid fibrils. Lewy body immunostained 
for AS fibrils. Figure adapted from Dobson, C.M. Nature (2003) 426, 884-890. 
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Figure 1.2  Pictorial depiction of the amino acid sequence of AS, natively unfolded and linear 
for clarity. Highlighted in red are the three pathogenic mutants A30P, A53T and E46K. In 
yellow, the GxxxG motif is highlighted and the negatively charged amino acids of the C-
terminus in magenta. The sixth characteristic KTKEGV imperfect repeats are highlighted in dark 
blue.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1  Notes and acknowledgements 
All experiments in the subsequent chapters were conducted by the following protocol unless 
otherwise indicated in the relevant chapter. I would like to thank Deborah Berthold and all of the 
undergraduate students for their help around the wet laboratory and for all the helpful 
discussions. 
2.2  Protein expression and purification 
Uniformly-15N, 13C labeled wild-type (WT), A30P, A53T and E46K α-synuclein (AS) 
samples were prepared by previously published protocols (1). Recombinant protein expression in 
E. coli BL21(DE3) proceeded in high yield (~60 mg per L) using minimal media supplemented 
with BioExpress (Cambridge Isotopes). The purification was performed by chemical lysis and 
two chromatographic steps (hydrophobic interaction and gel exclusion) a third of a liter at a time. 
The sample purity was confirmed by gel electrophoresis and mass spectrometry. This 
purification protocol was optimized by using larger chromatographic columns with the capacity 
of purifying a liter at a time, significantly reducing the protein purification time. In addition, 
Amicon stirred cell concentrators are now used to reduce loss from fibril formation due to over 
concentration. The revised protocol has reduced the bottleneck of AS fibril sample preparation. 
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2.3  α-Synuclein fibrillation 
Solutions of monomeric AS (1 mM, 50 mM phosphate buffer, pH 7.5, 0.02% azide, 0.1 mM 
EDTA) were syringe filtered (0.22 µm filters) into parafilmed, 1.7 mL Eppendorf ultra-
centrifuged tubes and samples were seeded with 15 µL of natural abundance, pre-generation AS 
fibrils per 500 µL of AS sample. Samples were then incubated with shaking (200 rpm) at 37 oC 
as previously described (1). Low pH fibrils were prepared in 50 mM acetate buffer, pH 5.0, 
0.02% azide and 0.1 mM EDTA.  
2.4  Thioflavin T fluorescence 
Solutions of monomeric WT and A30P AS (1 mM protein, 10 mM phosphate buffer at pH 
7.4, 2.7 mM KCl and 137 mM NaCl) were filtered, and fibril formation was measured by 
monitoring Thioflavin T (15 µM, Sigma Aldrich) fluorescence using established protocols (2). 
Control wells were prepared to account for light scatter and possible quenching. Ninety-six well 
plates were incubated at 37 °C and agitated for 16 minutes prior to each reading with four 
minutes of no agitation. Seven replicates were performed for each condition.  
2.5  Electron microscopy 
WT and A30P AS fibril samples were treated with Karnovsky’s fixative and negatively 
stained with 2% ammonium molybdate (w/v). Samples were applied on Formvar carbon coated 
grids (300 mesh) and were viewed with a Hitachi H600 Transmission Electron Microscope 
operating at 75 kV. 
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2.6  Solution NMR spectroscopy 
Monomeric AS samples were prepared for solution NMR experiments as 400 µL solutions 
containing 1 mM 15N labeled monomeric AS in 50 mM phosphate buffer (pH 7.5, 0.02% NaN3 
w/v, 0.1 mM EDTA), 10% D2O and 1 mM DSS. A two-dimensional (2D) BEST 1H-15N 
heteronuclear single-quantum correlation (HSQC) spectrum (3, 4) was acquired of WT and 
A30P AS monomeric samples, Figure 4.1. Solution NMR experiments were conducted on a 
Varian INOVA 14 Tesla (600 MHz, 1H frequency) spectrometer using a triple resonance (1H-
13C-15N), triaxial gradient probe utilizing VNMRJ version 2.1B software with BioPack. All 
solution NMR spectra were acquired at 0 oC. Solution NMR chemical shift assignments were 
based on published assignments posted on the Biological Magnetic Resonance data Bank 
(BMRB) with the accession numbers #16300 (5, 6) and #16546 (7, 8) for the WT and A30P, 
respectively.  
2.7  α-Synuclein fibril preparation and packing for solid-state NMR experiments 
All samples were washed by the following protocol with the exception of low pH AS fibril 
samples. After three weeks of fibrillation, samples were ultra-centrifuged for 1 h at 100,000 g. 
The resultant pellet from a 500 µL sample was washed with three aliquots of 100 µL Milli-Q 
water and ultra-centrifuged again for 1 h at 100,000 g. The supernatant was removed. 
AS fibril pellets were dried under a stream of N2 (g) until the final mass was unchanged (9). 
The sample was contained in an Eppendorf tube and left unexposed to its surroundings by 
poking two holes in the tube cap and directly allowing the N2 (g) stream to enter through one of 
the holes.  
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The dried pellets were packed into 3.2-mm (thin or standard wall) NMR rotors (Varian, Inc., 
Palo Alto and Walnut Creek, CA and Fort Collins, CO; now part of Agilent Technologies, Santa 
Clara, CA and Loveland, CO), rehydrated to 36% water by mass and kept hydrated by Kel-F and 
rubber spacers. Non-seeded AS fibrils were formed in the same conditions but incubated for a 
total of four weeks.  
2.8  Solid-state NMR data collection and analysis 
A 14.1 Tesla (600 MHz, 1H frequency) Varian Infinity Plus spectrometer equipped with a 
3.2-mm T3 Varian BalunTM 1H-13C-15N MAS probe, in triple resonance mode, was utilized to 
perform all SSNMR experiments. The experiments were acquired using tangent ramped cross 
polarization (10) and SPINAL-64 (11, 12) 1H decoupling with a field strength of ~75 kHz during 
acquisition and evolution periods. For 3D 15N-13C-13C and 13C-15N-13C correlation experiments, a 
band-selective SPECIFIC CP (13) was utilized for the heteronuclear polarization transfer 
between 15N and 13C and DARR (14) mixing for 13C homonuclear polarization transfer. All 
experiments were acquired under 13.3 kHz magic angle spinning and at a variable temperature of 
10 oC. The adamantane downfield peak was assumed to resonate at 40.48 ppm to externally 
reference chemical shifts (15).  
Data were processed with back linear prediction applied to the direct dimension. Zero filling, 
Lorentzian-to-Gaussian apodization and/or cosine bells were applied for each dimension before 
Fourier transformation using nmrPipe (16). Peak picking, assignments and peak heights were 
obtained with Sparky software (17) and NMRViewJ (18) using Gaussian peak integration 
methods.  
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CHAPTER 3 
OPTIMIZATION OF THE α-SYNUCLEIN FIBRIL PREPARATION 
FOR SOLID-STATE NMR 
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3.2  Abstract 
Sample reproducibility is very important for comparing different samples. Fibrillation 
conditions and hydration are two factors in sample reproducibility and spectral quality. We have 
carefully controlled buffer, pH, temperature and agitation conditions during fibrillation, which 
contribute to spectrally identical samples. We also found that washing samples to remove excess 
salt and soluble oligomeric species increases spectral resolution and facilitates the acquisition of 
multidimensional solid-state NMR experiments and the assignment of site-specific chemical 
shifts. In addition, we have optimized the hydration level for AS fibril samples and determined 
that 36% water by mass is a fair compromise between sensitivity and resolution. 
3.3  Improved spectral quality 
We have confirmed the well-known relative rates of fibrillation among WT, E46K, A53T 
and A30P, as discussed in more detail above (1-3). The time required to yield >90% of the 
protein as mature fibrils, starting with unseeded ~500 mM solutions, varies from a few days 
(A53T) to 3-4 weeks (A30P). Significant morphological differences have previously been 
observed as a function of AS mutation, concentration and time (1). However, we have succeeded 
in seeding samples to avoid the lag time associated with nucleation; this, along with careful 
control of the incubation conditions, has resulted in morphologically and spectroscopically 
identical samples from one batch to the next (4), Figure 3.1. This represented an essential step 
for the comparison of samples, as it is essential to distinguish between significant perturbations 
upon mutations and those caused by slight differences in sample preparation. Initially, after 
mature fibrils were formed, fibrils were dried manually with N2 (g) and required four workdays 
of manual time to avoid sample loss, because this method required the sample tube to be open 
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and exposed to its surroundings as fibrils were dried. Static and overestimations of high gas 
pressure caused sample to become air born and lost. The development of a simple device keeps 
the sample contained in the sample tube and left unexposed to its surroundings. Therefore, 
supervision is no longer required and sample loss is no longer an issue due to overestimation of 
gas pressure or static. Furthermore, the sample was dried within a few hours (dependent on 
sample quantity).  
These improved sample preparation methods have resulted in improved SSNMR spectral 
resolution and sensitivity, Figure 3.2. Initially, fibril solutions were directly packed into 3.2-mm 
standard wall rotors (Varian, Inc., Fort Collins, CO) after fibrillation (5). Data required 
extremely low temperature (-40 oC) and longer acquisition time due to less sample mass per 
volume and rigidity (6), Figure 3.2a. This preparation was improved by drying samples under a 
stream of N2 (g) until the mass was unchanged allowing for more protein capacity and less water 
in a 3.2-mm standard rotor (7), Figure 3.2b. The resolution was improved by re-hydrating the dry 
fibrils with 36% water by volume, Figure 3.2c. The latest optimal preparation consists of 
increased sensitivity when fibrils are washed (8) and double the sample quantity is packed into a 
3.2-mm thin wall rotor (Varian, Inc., Fort Collins, CO), Figure 3.2d; thin wall rotors hold 28 µL 
of material compared to standard wall rotors that only hold 18 µL. Fibrils were washed by re-
suspending the dry fibrils in water and then dried and re-hydrated. Washing samples removes 
monomer, soluble oligomeric species and excess salt. By removing monomer and oligomeric 
species from the sample, the sample homogeneity was increased and resulted in the sample’s 
natural linewidths to decrease. By removing excess salt from the sample, the tuning profile of the 
sample became stable and more decoupling power could be applied during acquisition and 
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evolution. To assess the extent of oligomerization that was removed during the wash, the 
supernatant of the wash was run through a size exclusion column and evidence of oligomers and 
monomer was present.  Overall, these advances increased spectral resolution and helped with the 
acquisition of experiments that require a higher decoupling power.  
3.4  Optimization of sample hydration 
Previous studies from our group have demonstrated the important effect of hydration to the 
resolution and sensitivity of the SSNMR spectra of full-length, α-synuclein fibrils (7). Here, we 
optimized the hydration level of AS fibrils to maximize the resolution and sensitivity of SSNMR 
multidimensional experiments, which are essential to complete chemical shift assignments. To 
optimize the hydration level, fibrils were dried by N2 (g) until no changes in mass were observed, 
and 1H 1D and 13C-13C 2D spectra were acquired (Figure 3.3). The hydration of the sample was 
gradually increased and 1H 1D and 13C-13C 2D spectra were acquired at each hydration level up 
to 50% (mass of water/total mass), as shown in Figure 3.3.  
As reported in Table 3.1, the pulse width for both for 1H and 13C became longer upon 
hydration and the overall cross-polarization efficiency decreased as expected. However, we 
observe significant improvement in the 13C linewidths and signal-to-noise of individual peaks 
(Table 3.1) that we hypothesize to be attributed to changes in the timescale of the dynamics of 
certain regions of the full-length protein. Average linewidths ± standard deviation and 
normalized signal-to-noise were obtained by measuring the linewidths and signal-to-noise for a 
total of 20 resolved peaks in 13C-13C 2D experiments. Conditions marked in bold correspond to 
the optimal conditions selected for multidimensional NMR experiments for all samples.  
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3.5  Conclusion 
AS is highly sensitive to fibrillation conditions, such as buffer, temperature pH and agitation, 
as seen in Hoyer et al. (9). Here we found that after carefully controlling fibrillation conditions, 
samples were highly reproducible. We also found that washing samples to remove excess salt 
and soluble oligomeric species increased sample homogeneity. This increases spectral resolution 
facilitating the acquisition of multidimensional SSNMR experiments and the assigning of site-
specific chemical shifts. Chemical shifts are highly sensitive to their environment, especially 
hydration (7). Thus, we have optimized the hydration level for AS fibril samples and found that 
36% water by mass was the best compromise between resolution and sensitivity. 
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3.7  Figures 
 
 
Figure 3.1  Microscopically ordered AS fibrils. (a) 13C-13C 2D spectrum of U-13C, 15N AS fibrils 
with 36% water by mass (50 ms DARR mixing, 750 MHz 1H frequency and 16.7 kHz MAS 
rate). (b) Transmission electron micrographs of AS fibrils. (c) Correlations of 13CA, 13CB and 
13C’ AS chemical shifts (CS) from independent sample preparation batches (above) seeded with 
unlabeled fibrils and (below) unseeded.  
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Figure 3.2  Comparison of 13C-13C 2D spectra of AS fibrils. (a) Fully hydrated AS fibrils 
acquired on a 600 MHz spectrometer, 7 mg, 2.2 h. (b) Dried AS fibrils acquired on a 500 MHz 
spectrometer, 10 mg, 1.7 h. (c) Re-hydrated AS fibrils acquired on a 500 MHz spectrometer, 10 
mg, 1.8 h. (d) Re-hydrated AS fibrils acquired on a 600 MHz spectrometer, 25 mg, 2.2 h. All 
spectra were acquired at 0 oC with the exception of (a), which was acquired at -40 oC. All spectra 
were acquired with 10 ms DARR mixing with the exception of (c), which was acquired with 25 
ms DARR mixing. Spectra were processed identically, with 0.26 ppm line broadening in both 
dimensions, and drawn with contours 5 times the noise level. A and B are figures adapted from 
Kloepper, K. D.; Hartman, K. L.; Ladror, D. T.; Rienstra, C. M.; (2007) J. Phys. Chem. B, 111, 
13353-13356. 
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Figure 3.3  Optimization of hydration for α-synuclein fibril samples for SSNMR experiments 
(mass of water/total mass). (a) 1H 1D spectra of U-13C, 15N AS fibrils at different hydration 
levels (dry, 16%, 26%, 36% 44% and 50%) and (b) 13C-13C 2D spectra with 50 ms DARR 
mixing. All spectra were acquired under identical conditions at 600 MHz (1H frequency) and 
13.3 kHz MAS rate. (*) Dry fibrils correspond to fibrils dried by N2 gas until no changes in mass 
were observed, as previously described (6). Spectra marked in blue correspond to the optimal 
conditions selected for the multidimensional NMR experiments.  
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3.8  Tables 
Table 3.1  Comparison of 1H and 13C pulse widths (PW), CP enhancement and 13C linewidths 
(Hz) at different percentages of hydration (mass of water/total mass) for U-15N, 13C WT AS 
fibrils. (*) Dry fibrils correspond to fibrils dried by N2 gas until no changes in mass were 
observed, as previously described (6). Average linewidths (LW) ± standard deviation were 
obtained by measuring the LW for a total of 20 resolved peaks in 13C-13C 2D experiments at 600 
MHz (1H frequency) and 13.3 kHz MAS. 
 
Hydration 
(water by 
mass) 
13C PW 
(µs) 
1H PW 
(µs) 
Cross 
Polarization 
enhancement 
Average 
13C LW 
(Hz) 
Normalized 
signal-to-
noise 
Dry fibrils (*) 1.90±0.05 2.00±0.05 1.91±0.07 141±44 0.76±0.06 
16% 1.90±0.05 2.05±0.05 1.73±0.06 125±45 0.82±0.05 
28% 1.90±0.05 2.05±0.05 1.70±0.06 104±45 0.84±0.05 
36% 1.95±0.05 2.15±0.05 1.57±0.06 88±44 0.90±0.05 
44% 1.95±0.05 2.15±0.05 1.40±0.06 95±42 1.00±0.04 
50% 1.95±0.05 2.20±0.05 1.31±0.07 93±45 0.94±0.04 
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CHAPTER 4 
A30P α-SYNUCLEIN ADOPTS THE WILD-TYPE FIBRIL STRUCTURE, 
DESPITE SLOWER FIBRILLATION KINETICS  
4.1  Notes and acknowledgements 
This chapter is adapted has been submitted to the Journal of Biological Chemistry for peer 
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kinetics, authors: Luisel R. Lemkau, Gemma Comellas, Kathryn D. Kloepper, Wendy S. Woods, 
Julia M. George and Chad M. Rienstra. We thank Kem Winter and Shin Lee for assisting with 
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collection. L.R.L. thanks the National Institutes of Heath Research Supplements to Promote 
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4.2  Abstract 
α-Synuclein (AS) is associated with both sporadic and familial forms of Parkinson’s disease 
(PD). In sporadic disease, wild-type AS fibrillates and accumulates as Lewy bodies within 
dopamine neurons of the substantia nigra. The accumulation of misfolded AS is associated with 
the death of these neurons, which underlies many of the clinical features of PD. In addition, a 
rare missense mutation in AS, A30P, is associated with highly penetrant, autosomal dominant 
PD, although the pathogenic mechanism is unclear. A30P AS fibrillates more slowly than the 
wild-type protein in vitro, and has been reported to preferentially adopt a soluble, protofibrillar 
conformation. This has led to speculation that A30P forms aggregates that are distinct in 
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structure as compared to wild-type AS. Here we perform a detailed comparison of the chemical 
shifts and secondary structures of these fibrillar species, based upon our recent characterization 
of full-length wild-type fibrils. We have assigned A30P AS fibril chemical shifts de novo and 
used them to empirically determine its secondary structure. Our results illustrate that although 
A30P forms fibrils slower than WT, their chemical shifts and secondary structure are in high 
agreement, demonstrating a conserved β-sheet core. 
4.3  Introduction 
Alpha-synuclein (AS) is centrally implicated in Parkinson’s disease (PD) and several other 
neurodegenerative disorders (1). The unifying feature of the “synucleinopathies” is aggregation 
and accumulation of AS protein within intracellular inclusions (2). While these diseases are 
typically sporadic, several mutations in the SNCA gene encoding AS are associated with familial 
PD, including single point mutations—A53T (3), A30P (4) and E46K (5)—and allele duplication 
(6) or triplication (7). 
Although the PD-associated AS mutations are extremely rare, analysis of their pathogenicity 
could significantly illuminate the mechanisms underlying sporadic disease. The normal function 
of AS is not precisely known, but it shares conserved structural features with the exchangeable 
apolipoproteins (8), and several lines of evidence suggest a role for AS in presynaptic vesicle 
trafficking (9-11). Like the wild-type (WT) protein, all mutant forms of AS are intrinsically 
unfolded in aqueous solution, but adopt an α-helical secondary structure within their N-termini 
upon binding to phospholipid vesicles or detergent micelles (12, 13). Within A30P, the helical 
domain is partially disrupted by proline substitution, with a consequent decrease in lipid affinity 
(12), while the A53T and E46K mutants exhibit similar or enhanced lipid binding when 
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compared to WT AS (12, 14). Thus, altered lipid affinity is not a unifying phenotype for disease-
associated mutants. 
One hypothesis to account for the pathogenicity of the PD-related mutations is that they 
promote pathological AS aggregation. However, A30P AS has been reported to fibrillate more 
slowly than WT AS in vitro (15), and to preferentially populate a soluble, protofibrillar 
intermediate, whereas WT readily progresses to mature, insoluble fibrils (16). This has fueled 
speculation that the mechanism of A30P toxicity may be fundamentally different than that of WT 
AS. Only recently has tissue from a familial PD patient with the A30P mutation has become 
available for analysis. This individual displayed neuropathology typical of idiopathic PD, but 
with a greater-than-typical load of insoluble fibrillar aggregates (17). This is a surprising result 
that strongly implicates fibrillar AS in the pathogenesis of A30P-dependent PD. 
A30P and WT AS fibrils have similar morphologies when viewed by low resolution 
techniques, like electron microscopy (18). Although recent solution NMR studies of quenched 
hydrogen/deuterium (H/D) exchange have suggested that the A30P mutation does not to perturb 
the location or arrangement of β-strands in WT AS fibrils (19), it is not possible to draw site-
specific conclusions regarding structure from H/D exchange experiments alone; for example, 
some β-sheet regions may be more exposed than others or protected regions may not exhibit a β-
sheet secondary structure. In addition, these indirect measurements rely on low molecular weight 
samples, which require fibrils to be broken down to smaller units because of their high molecular 
weight. In contrast, solid-state NMR (SSNMR) is uniquely positioned to obtain atomic-
resolution structural information of systems that are of high molecular weight, not soluble and do 
not form crystals, such as AS fibrils, without altering sample integrity. In this study, we sought to 
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determine whether A30P AS fibrils differ at an atomic level in secondary structure from WT AS 
fibrils. Our results, based on chemical shift analysis obtained with multidimensional SSNMR 
experiments, illustrate that A30P and WT AS fibrils are highly similar in secondary structural 
details. 
4.4  Materials and methods 
4.4.1  Protein sample preparation 
Natural abundance and uniformly 13C, 15N labeled WT and A30P full-length, monomer 
samples were expressed and purified as previously described (20). Briefly, recombinant protein 
was expressed in E. coli BL21(DE3), while grown in minimal media supplemented with 13C, 15N 
BioExpress (Cambridge Isotopes). Purification was performed by thermal lysis, hydrophobic 
interaction and size exclusion chromatography resulting in high yield (>40 mg per liter). The 
sample purity was confirmed by gel electrophoresis and mass spectrometry. To verify that the 
mutation was present, the plasmid was sequenced and 1H-15N HSQC spectra of the purified 
monomer samples were acquired, as shown in Figure S1.  
4.4.2  Thioflavin T fluorescence 
Solutions of monomeric WT and A30P AS (1 mM, 10 mM phosphate buffer, 2.7 mM KCl, 
137 mM NaCl, pH 7.4) were filtered, and fibril formation was measured by monitoring 
Thioflavin T (15 µM, Sigma Aldrich) fluorescence using established protocols (21). Control 
wells were prepared to account for light scatter and possible quenching. Ninety-six well plates 
were incubated at 37 °C and agitated for 16 minutes prior to each reading with 4 minutes of no 
agitation. Seven replicates were performed for both A30P and WT AS.  
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4.4.3  Electron Microscopy 
WT and A30P AS fibril samples were treated with Karnovsky’s fixative and negatively stained 
with 2 % ammonium molybdate (w/v). Samples were applied on formvar carbon coated grids 
(300 mesh) and were viewed with a Hitachi H600 Transmission Electron Microscope, operating 
at 75 kV. 
4.4.4  Solution NMR spectroscopy 
Monomeric AS samples were prepared for solution NMR experiments as 400 µL solutions 
containing 0.33 mM 15N labeled monomeric AS in 50 mM phosphate buffer (pH 7.5, 0.02% 
NaN3 w/v), 10% D2O and 1 mM DSS. A two-dimensional (2D) BEST 1H-15N heteronuclear 
single-quantum correlation (HSQC) spectrum (22, 23) was acquired of WT and A30P AS 
monomeric samples, Figure 3.1. Solution NMR experiments were conducted on a Varian 
INOVA 14 Tesla (600 MHz, 1H frequency) spectrometer using a triple resonance (1H-13C-15N) 
triaxial gradient probe, utilizing VNMRJ version 2.1B software with BioPack. All solution NMR 
spectra were acquired at 0 oC. Chemical shift assignments labeled in Figure S1 are based on the 
published assignments that are deposited on the Biological Magnetic Resonance data Bank 
(BMRB) with the accession numbers #16300 (24, 25) and #16546 (26, 27) for the WT and 
A30P, respectively. The amide proton chemical shift of A30 is reported to be 8.26 ppm and 
123.54 ppm of the amide nitrogen for the WT monomer. We did not see a correlation at these 
frequencies in either spectrum. However, we found that the chemical shifts of A29 and G31-T33 
had been perturbed as previously described upon mutation. 
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4.4.5  Solid-state NMR spectroscopy 
An initial solution of monomeric, natural abundance A30P AS (1 mM protein, 50 mM 
phosphate buffer, pH 7.5, 0.02% azide and 0.1 mM EDTA) was filtered with a 0.22 µm syringe 
filter. This solution was incubated with shaking (200 rpm) at 37 oC for 3 weeks to produce 
mature fibrils. These fibrils were then used to seed future uniformly 13C, 15N labeled A30P AS 
fibrils. After the allotted time, fibril solutions were washed, dried, packed into 3.2 mm standard 
or thin wall rotors (Varian, Inc., Fort Collins, CO) and rehydrated with 36% (m/v) of water as 
per previously described protocols (28).  
A 14.1 Tesla (600 MHz, 1H frequency) Varian Infinity Plus spectrometer equipped with a 3.2 
mm T3 Varian BalunTM 1H-13C-15N MAS probe, in triple resonance mode, was utilized to 
perform all SSNMR experiments. Experiments employed tangent ramped cross polarization (29) 
and SPINAL-64 (30, 31) 1H decoupling with a field strength of ~75 kHz during acquisition and 
evolution periods. For 3D 15N-13C-13C and 13C-15N-13C correlation experiments, band-selective 
SPECIFIC cross polarization (CP) (32) was utilized for heteronuclear polarization transfer 
between 15N and 13C and DARR (33) mixing for 13C homonuclear polarization transfer. All 
experiments were acquired under 13.3 kHz magic angle spinning and at a variable temperature of 
10 oC. The adamantane downfield peak was assumed to resonate at 40.48 ppm to externally 
reference chemical shifts (34). All 2D and 3D spectra used for chemical shift assignments are 
listed in Table S1. 
Data were processed with back linear prediction applied to the direct dimension. Zero filling, 
Lorentzian-to-Gaussian apodization and/or cosine bells were applied for each dimension before 
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Fourier transformation using nmrPipe (35). Peak picking, assignments and peak heights were 
obtained with Sparky software (36) using Gaussian peak integration methods.  
4.5  Results and discussion 
4.5.1  A30P α-synuclein fibrillates slower than WT 
WT and A30P AS solutions were prepared, as previously described (20), to monitor fibril 
formation with Thioflavin T fluorescence. An increase in lag time indicates a decrease in the 
fibrillation rate, as shown for A30P when compared to WT (Figure 3.2a). Our data show WT AS 
to propagate after 24 hours and A30P after 72 hours. These results are in agreement with those of 
Li et al. (37) and Meuvis et al. (38). Although A30P and WT fibrillate at different rates, a 
comparison of electron micrographs of mature fibrils, formed after three weeks of incubation, 
exhibit no distinguishable changes in the fibril morphology upon mutation (Figure 3.2b). 
4.5.2  A30P α-synuclein fibrils are highly reproducible 
SSNMR has proven to be a useful structural biology technique in exploring the structure and 
dynamics of amyloid fibrils, like AS fibrils (39-41). Certain amino acids (i.e., Gly, Ala, Thr, Ser, 
Ile, and Pro) are distinctively identifiable by their unique chemical shift patterns and are highly 
sensitive to secondary structure (42-46). Therefore, to evaluate slight variations between one 
fibril batch to the next, 13C-13C 2D spectra with 50 ms DARR (47) mixing were acquired of three 
different batches of A30P AS fibrils; prepared as previously described for uniformly 13C, 15N 
labeled WT AS fibrils (20, 28). The linear regression analysis of two individual batches showed 
R2 values of 0.996, 0.999 and 0.999 for 13C’, 13CA and 13CB, respectively (Figure 3.2c-e). 
Independent batches also exhibit average chemical shift variations of less than 0.2 ppm. Our 
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A30P fibril samples are microscopically well-ordered, evidenced by the narrow line widths, 
averaging 0.2 ppm (Figure 3.2f). Many of the spectral fingerprints of A30P AS fibrils are 
identical to those of WT; for example, the highly resolved Thr and Ser regions, shown in Figure 
1g and 1h.  
4.5.3  A30P α-synuclein fibril chemical shift assignments 
SSNMR heteronuclear (15N-13C) and homonuclear (13C-13C) 2D experiments with longer 
DARR mixing times were acquired on uniformly 13C, 15N labeled A30P AS fibrils to detect 
intra- and inter-residue correlations and confirm pair-wise assignments. Some signal patterns 
could be assigned immediately, but the majority of correlation patterns were degenerate due to 
the presence of sequential, imperfect repeats (KTKEGV) in the AS N-terminus. Accordingly, 3D 
experiments (Table 3.1) were acquired to obtain unambiguous, site-specific chemical shift 
assignments. 
15N-13C-13C 3D experiments detect a common nitrogen frequency to associate two 
neighboring residues (the i and i -1 residues). Additionally, 13C-15N-13C 3D experiments can be 
used to gain an added common frequency such as 13CA or 13C’ in the second dimension. For 
example, a CAN(co)CX starts with 13C polarization on 13CA nuclei and is transferred to 15N 
nuclei; this is followed by a polarization transfer from 15N to 13C’ nuclei (where no chemical 
shift evolution takes place, hence the parenthesizes) using specific cross polarization (48). Once 
these cross polarization transfers have occurred, the resulting polarization on the 13C’ nucleus is 
transferred dispersedly through space to the side chain 13C nuclei using the DARR mixing 
scheme. Using these three multidimensional experiments, we conducted chemical shift 
assignments of sequential residues using the backbone walk method, a well-established 
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technique for making de novo site-specific chemical shift assignments (28, 49-55). Figure 3.3 
illustrates how the backbone walk method is used to assign seven consecutive residues in A30P 
AS fibrils. Sequential backbone assignments were achieved for the stretches of V40-V49, G51-
V55 and E57-D98 (Figures 3.4 and 3.5). A total of 63 unique de novo resonance assignments 
were possible for A30P AS fibrils (Table 3.2) without relying upon the WT AS chemical shift 
lists.  
In fact, the resolution and sensitivity of A30P AS fibril spectra were so favorable that a 
number of signals were detected in the loop regions that were not evident in comparable spectra 
of WT AS fibrils: E57, E61 and D98. Residues Y39 to K43, K58 to K60, Q62 and K97, 
highlighted in Table 3.2, were previously assigned for WT AS fibrils from data acquired on 13C 
sparsely labeled samples (28), which provide higher resolution data compared to uniformly 13C 
labeled samples (56). These residues were detected and assigned using uniformly 13C labeled 
A30P fibril samples. We attribute these results to technical improvements in the data collection 
and potential contributions from differences in the dynamics of the loop regions. 
4.5.4  A30P a-synuclein forms fibrils that are structurally similar to wild-type 
We applied linear regression analysis to the complete set of WT (28) and A30P AS fibril 
chemical shifts (Figure 3.6). The chemical shifts of 13CA and 13CB are highly sensitive to 
secondary structure confirmation; thus, R2 values of 0.999 and 0.998, respectively, confirm 
nearly identical secondary structures between A30P and WT AS fibrils. The 15N and 13C’ 
chemical shifts exhibit R2 values of 0.998 and 0.991, respectively, which are consistent with 
modest perturbations in hydrogen bonding and electrostatics upon mutation (57, 58). 
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As previously demonstrated (59), the dipolar-based CANCO experiment produces a 
correlation for the most rigid residues in a given sample. Amyloid fibrils contain a rigid core, 
where dipolar-based experiments transfer polarization with high efficiency, and mobile regions, 
where polarization transfer is difficult or not allowed in dipolar-based experiments (40, 60). 
Thus, the signal intensities report qualitatively on rigidity. Sixty-one correlations were identified 
in the CANCO spectrum of A30P AS fibrils of the expected 140 residues in AS. Of the 
correlations detected in the CANCO spectra, 91% were unambiguously assigned. Figure 3.7c 
demonstrates the trend in signal intensity by residue number for A30P AS fibrils. The region 
with the greatest intensity is found for residues 68 to 94, which includes the most hydrophobic 
stretch, 71-82 (61). We attribute the missing signals in the CANCO spectra of full-length A30P 
AS fibrils to mobility in dipolar-based experiments. Polarization is transferred through-space in 
dipolar experiments, which is more efficient between two rigid nuclei. Therefore, more mobile 
regions like the termini and those in loop confirmations are less likely to be detected by dipolar-
based experiments. 
SSNMR detects differences in chemical environments with high sensitivity (43-46, 62). This 
allows for the identification of amino acids and prediction of backbone dihedral angles (Φ and 
Ψ) and secondary structure with the TALOS+ program, illustrated in Figures 3.7a and 3.7b (44, 
63). Our results pertaining to A30P AS fibrils indicate a highly similar β-sheet secondary 
structure relative to the WT (28), Figure 3.7a. This is consistent with the localization of A30 
outside the stable β-sheet core for the WT fibril structure, thus exerting no major effect on the β-
sheet secondary structure of the core upon mutation (28). The improvement in data quality of 
A30P AS fibrils allowed for the detection of additional residues, which also allowed for an 
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extended, empirically determined secondary structure compared to the WT in the V55-V63 
region. In addition, when the chemical shifts of this region were compared between A30P and 
WT AS fibrils, perturbations greater than 0.5 ppm for V55, K58, K60 and V63 were found, 
which are greater than the variations found between individual sample preparations, < 0.2 ppm. 
Considering that these perturbations correspond to a similar region of the protein, these results 
suggest that the location of A30 in the WT AS fibril structure alters the packing of the fibril in 
this region. Presume three possible scenarios: (1) this region and A30 are in close proximity with 
in the WT fold, (2) there is an intermolecular interaction between this region on one molecule 
and position A30 of a second molecule or (3) the N-terminal domain is perturbed relative to the 
WT. In the latter of these possibilities, the N-terminal domain is more dynamic than the rest of 
the fibril core; therefore, such perturbations are not detected in dipolar experiments, as we do not 
observe these signals. Significantly, Goedert and coworkers report that the truncation of the N-
terminal domain of AS causes an increase in the fibrillation lag time of WT AS (65). This 
demonstrates that the intact N-terminal domain plays a role in promoting fibrillation, and 
suggests a mechanism whereby disruption of the N-terminal domain (via proline substitution at 
A30) might inhibit fibrillation kinetics without altering the fibril structure. This together leads to 
the hypothesis that the A30P mutation affects the susceptibility to form fibrils, hence the 
propensity to form more oligomeric species than mature fibrils (66). Although in vitro fibril 
formation is slower than for the WT, one could also envision differences in the fibrillation 
kinetics in cellular environments. This would also be consistent with the presence of a greater-
than-typical load of insoluble fibrillar aggregates in brain of the familial PD patient with the 
A30P mutation (17). 
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4.6  Conclusion 
We have performed a site-specific comparison between the secondary structures of full-
length WT and A30P AS fibrils. Chemical shift assignments and the empirically determined 
secondary structure demonstrate that A30P adopts the wild-type fibril structure, despite the fact 
that A30P forms fibrils more slowly. Our results show that the A30P mutation does not 
substantially perturb the resulting AS fibril secondary structure at an atomic level.   
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4.8  Figures 
 
 
 
Figure 4.1  Solution NMR demonstrates the A30P mutation was present before fibrillation. (a) 
Overlaid 1H-15N HSQC spectra of A30P (blue) and WT (red) purified AS monomer. 
Expansions of residues near mutation site: (b) G31, (c) T33, (d) K32 and (e) A29. Assignments 
based on the deposited solution assignments from the BMRB for WT # 16300 (25) and A30P 
#16546 (27). 
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Figure 4.2  In vitro fibrillation conditions provide microscopically well-ordered A30P AS fibrils 
that form slower than WT. (a) Average fibril formation assay of (red triangles) WT and (blue 
circles) A30P AS fibrils monitored by Thioflavin T fluorescence. Error bars were determined 
from seven replicates for each. (b) Comparison of the electron micrographs of (left) WT and 
(right) A30P AS fibrils. (a) 13C’, (b) 13CA and (c) 13CB chemical shift plots between two 
individual batches of A30P AS fibrils. (d) 13C-13C 2D with 50 ms DARR mixing of A30P AS 
fibrils. Overlaid expansions of WT (red) on to A30P (blue) AS fibrils for the (e) Thr/Ser (CB-C’) 
and (f) Thr/Ser (CB-CA) regions. 
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Figure 4.3  Multidimensional spectra with high sensitivity and resolution allowed for the 
chemical shift assignments of A30P AS fibrils. (left) Backbone walk schematic. (right) 
Illustration of backbone connectivity through the NCACX (red), NCOCX (blue) and 
CAN(co)CX (orange) spectra of residues V71-N65 for A30P AS fibrils. All spectra acquired 
with 50 ms DARR mixing and processed with 0.5 ppm of line-broadening in each dimension. 
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Figure 4.4  Backbone walk scheme using NCACX (red) with 50 ms DARR, CAN(CO)CX 
(orange) with 50 ms DARR and NCOCX (blue) with 100 ms DARR spectra of A30P AS fibrils; 
residues D98 to T72. Spectra were acquired at 10 oC and 13.3 kHz MAS. Acquisition and 
processing details are described above. 
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Figure 4.5  Backbone walk scheme using NCACX (red) with 50 ms DARR, CAN(CO)CX 
(orange) with 50 ms DARR and NCOCX (blue) with 100 ms DARR spectra of A30P AS fibrils; 
residues V71 to G41. Spectra were acquired at 10 oC and 13.3 kHz MAS. Acquisition and 
processing details are described above. 
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Figure 4.6  Comparison of the chemical shift assignments of A30P and WT AS fibrils (28) 
demonstrates that the fibril is mostly unchanged upon A30P mutation. (a) 15N, (b) 13CA, (c) 13C’ 
and (d) 13CB chemical shift plots of WT versus A30P AS fibrils. Residues that differ by more 
than 0.5 ppm are labeled and highlighted with blue circles.  
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Figure 4.7  Comparison of the secondary structures between WT (28) and A30P AS fibrils 
demonstrates that the fibril core is mostly unchanged upon A30P mutation. (a) Representation of 
the secondary structure of WT (red) and A30P (blue) AS fibrils based on TALOS+ analysis (β-
strands, arrows; turn or loop curved lines; not predicted, dashed lines). (b) TALOS+ predicted 
backbone dihedral angles φ (black squares) and ψ (gray circles), error bars based on the 10 best 
TALOS+ database matches and (c) the normalized peak heights from CANCO as a function of 
residue number for A30P. 
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4.9  Tables 
 
Table 4.1  Description of the 2D and 3D experiments acquired in order to obtain the de novo 13C, 
15N chemical shift assignments for U-13C, 15N A30P AS fibrils. Chemical Shifts were deposited 
to the BMRB, entry #17214. The total amount of protein was calculated based on the intensity of 
a 13C 1D DP experiment versus that of adamantane (the mass for adamantane was determined 
before packing the sample in the rotor).  
 
Experiments Dimensions acquired 
Mixing time and 
sequence 
Acquisition 
Time (hrs) 
Amount of 
sample (mg) 
CC 2D 50 ms DARR 11 ~20 
CC 2D 250 ms DARR 9 ~20 
CC 2D 500 ms DARR 58 ~20 
N(CA)CX 2D 50 ms DARR 19 ~10 
N(CA)CX 2D 200 ms DARR 10 ~20 
NCACX 3D 50 ms DARR 110 ~10 
NCACX 3D 200 ms DARR 100 ~20 
N(CO)CX 2D 50 ms DARR 16 ~10 
N(CO)CX 2D 250 ms DARR 48 ~20 
NCOCX 3D 100 ms DARR 120 ~10 
NCOCX 3D 250 ms DARR 180 ~20 
CA(NCO)CX 2D 50 ms DARR 14 ~20 
CANCO 3D ---- 42 ~20 
CAN(CO)CX 3D 50 ms DARR 135 ~20 
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Table 4.2  13C and 15N chemical shift assignments of A30P AS fibrils (with 36% water by mass) 
using only uniformly labeled samples. Chemical shifts were deposited to the BMRB, entry 
#17214. WT-AS fibril assignments were made with data acquired on samples with selected 13C 
labeling indicated by an asterisk (*) and assignments not possible with either selected or uniform 
labeling are indicated in bold. Assignments in italics are tentative for A30P fibrils. 
 
Residu
e 
15N 13C’ 13CA 13CB 13CG 13CD 13CE 13CZ 15ND 15NE 
Y39 --- --- 54.3* 35.4* --- --- --- ---   
V40 126.4* 176.4 61.1* 35.5*       
G41 115.2* 174.5* 48.4*        
S42 112.1* 171.5* 58.6* 67.4*       
K43 122.8* 175.7* 54.7* 38.0* 25.8* 31.1* 41.9*    
T44 113.5 175.3 59.6 71.5 22.3      
K45 122.5 173.8 56.2 37.0 27.5 30.8 42.3    
E46 126.4 175.0 54.0 32.5 35.1 182.9     
G47 115.6 172.7 48.4        
V48 118.5 174.6 59.6 37.7 24.0/20.
8 
     
V49 126.6 174.7 61.6 34.0 23.0/21.
2 
     
G51 --- 175.8 44.9*        
V52 124.1 174.7 61.3 34.0 21.2/20.
7 
     
A53 132.9 175.8 50.0 21.2       
T54 121. 4 173.4 61.6 71.5 22.0      
V55 126.8 --- 60.8 34.2 23.2/22.
8 
     
E57 --- 175.5 50.2 34.1 35.7 ---     
K58 123.3 176.5* 54.0* 36.3* 25.9* 32.8* 42.1*    
T59 122.5* 174.3* 67.2 67.3 22.7      
K60 121.7* 173.7 55.7* 35.6 26.5 32.2 42.5    
E61 128.3 174.8 54.2 33.6 36.5 183.0     
Q62 --- 175.1* 49.3 34.7 35.6 ---    --- 
V63 122.9 175.2 61.1 35.4 21.3/20.
4 
     
T64 126.6 172.7 62.2 69.8 21.8      
N65 125.2 172.6 51.8 42.9 175.2    115.0  
V66 127.4 177.8 60.7 33.2 21.2/20.
0 
     
G67 111.2 172.7 46.5        
G68 102.8 172.4 43.3        
A69 126.4 175.4 50.3 23.4       
V70 120.6 174.6 60.1 35.7 21.5      
V71 126.3 176.5 61.0 35.2 22.0/20.
9 
     
T72 115.0 175.3 59.5 69.6 22.1      
G73 108.6 173.4 43.9        
V74 124.2 175.1 61.4 34.9 21.0/19.
6 
     
T75 127.7 172.1 61.7 70.5 21.4      
A76 130.3 174.4 49.7 21.4       
V77 123.8 172.9 60.5 35.9 21.3/20.
4 
     
A78 130.0 176.4 49.9 25.0       
Q79 120.1 176.6 52. 5 33.1 33.3 177.6    110.8 
K80 122.9 176.1 60.3 32.5 26.6 31.5 42.3    
T81 113.2 173.7 60.9 72.4 22.5      
V82 126.1 174.9 61.5 34.1 21.5/20.
7 
     
E83 126.1 175.2 53.8 33.8 35.8 182.9     
G84 112.6 173.6 45.0        
A85 131.0 179.3 53.3 18.6       
G86 110.7 173.8 46.7        
S87 115.7 173.5 58.8 64.9       
I88 121.5 175.7 60.1 40.5 27.4/17.
6 
13.5     
A89 129.4 176.9 54.9 18.8       
A90 123.1 174.8 51.3 21.0       
A91 127.5 175.6 49.6 23.1       
T92 125.5 174.7 61.0 70.0 21.8      
G93 114.5 170.1 47.4        
F94 126.4 173.3 54.6 45.4 138.4 132.4/132
.2 
131.0/130
.7 
129.4   
V95 127.9 171.5 61.1 34.9 22.1/20.
7 
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Table 4.2,  continued 
Residu
e 
15N 13C’ 13CA 13CB 13CG 13CD 13CE 13CZ 15ND 15NE 
K96 133.1 173.2 54.9 38.0 25.9 31.0 42.7    
K97 130.7* 175.1 54.1* 34.3 25.6 --- 42.2    
D98 124.0 177.1 55.1 42.6       
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CHAPTER 5 
STRUCTURAL PERTURBATIONS FOUND UPON MUTATION OF 
ALPHA-SYNUCLEIN TO A53T AND E46K IN THE FIBRIL STATE 
5.1  Notes and Acknowledgements 
This chapter is based on a manuscript with the same title that is currently under preparation. 
L.R.L. thanks the National Institutes of Heath Research Supplements to Promote Diversity in 
Health-Related Research (GM073770-02 S1 SUPP) and the Novartis Pre-doctoral Fellowship. 
G.C. thanks the Caja Madrid Foundation Graduate Fellowship. Funding for the 750 MHz 1H 
frequency spectrometer used to acquire the A53T AS fibril data were provided by Award 
Number S10RR025037 from the National Center For Research Resources. The content is solely 
the responsibility of the authors and does not necessarily represent the official view of the 
National Center For Research Resources or the National Institutes of Health. 
5.2  Abstract 
Parkinson’s disease (PD) is associated with an aggregated protein, α-synuclein (AS), found 
in Lewy bodies within dopamine neurons of the substantia nigra of PD patients. AS is further 
related to PD by the presence of three single point mutations A30P, E46K and A53T in the 
familial form. Of these the A53T mutation is unique in that there is a threonine instead of an 
alanine at position 53 for non-primate mammals, while the other two single point mutations are 
conserved. Mice expressing human E46K or A53T AS form display AS inclusions closely 
resembling those of Human Lewy Bodies. This evidence further supports the relationship 
between AS fibrils and PD pathology, which has lead to several investigations into the anomalies 
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and similarities between the wild-type (WT) and mutants in hopes to acquire knowledge related 
to PD etiology. Here, we have compared in detail the chemical shifts, secondary structures and 
conformational dynamics of the E46K and A53T AS fibrillar species with our recent 
characterization of full-length wild-type fibrils. We have acquired multidimensional solid-state 
NMR experiments in order to assign the E46K and A53T AS fibril chemical shifts de novo and 
use them to empirically determine their secondary structure. Our detailed comparison illustrates 
large perturbations upon the E46K mutation that leads to major changes in secondary structure. 
In addition we find a similar secondary structure between A53T and WT AS fibrils, with slight 
perturbations near the mutation site, the 60s and 80s.  
5.3  Introduction 
Alpha-synuclein (AS) is a widely studied protein for its relevance to Parkinson’s disease 
(PD) and other neurodegenerative diseases (1). Aggregated AS is the main proteineous 
component found in Lewy bodies, the pathological hallmark of PD (2). The native function of 
AS is not well understood, however, it has conserved structural motifs found in exchangeable 
apolipoproteins (3) and several results point towards a role in presynaptic vesicle trafficking (4-
6). In addition, AS is further implicated in PD pathology through the finding of three single point 
mutations–A30P (7), E46K (8) and A53T (9)—and allele duplication (10) and triplication (11) in 
the familial form of PD. 
Several investigations into the anomalies and similarities between the wild-type (WT) and 
mutants have been conducted in hopes to acquire knowledge related to PD etiology. The A30P 
and E46K mutations are conserved across a variety of species, however A53T is not. A threonine 
is present instead of an alanine at position 53 for non-primate mammals along with six other 
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substitutions: S87N, L100M, N103G, A107Y, D1221G and N122S (9). Elevated 
neurodegenerative effects are displayed in mice expressing human A53T AS (12-18); this 
suggests that these additional substitutions may add a complementary physiological effect to 
A53T. Similarly, mice expressing human E46K AS form AS inclusions closely resembling those 
of Human Lewy Bodies (19). These results further support the relationship between AS fibrils 
and PD pathology. 
All three familial mutants, along with the WT, are unstructured in solution with the exception 
of residual secondary structure near the mutation sites (20-22). In addition, these mutants 
illustrate an α-helical N-terminal domain upon binding to phospholipid vesicles or detergent 
micelles, with an affinity similar to that of WT (22-25). However, the mutants differ from the 
WT when considering their fibrillation kinetics. A53T (26-29) and E46K (22) form fibrils faster 
than WT (24, 30), while A30P fibrillates much slowly (27, 31). Through atomic force and 
electron microscopy, the WT and mutant AS fibrils have been shown to have an overall similar 
morphology (24, 32, 33). However, these methods do not give atomic level structural 
information on how the wild-type fibril structure is perturbed upon mutation.  
An emerging technique in structural biology is magic angle spinning solid-state NMR 
(SSNMR). Because amyloid fibrils, like AS, are not soluble and do not form x-ray diffractable 
quality crystals, many scientist resort to SSNMR, indifferent to these issues, to investigate such 
systems. Much progress has been made towards solving amyloid fibril structures using 
SSNMR(34-38). For example, the latest being that of amyloid β (39, 40). 
Most recently we used SSNMR to report that despite the slower kinetics of A30P AS fibril 
formation, the A30P mutation does not affect the WT secondary structure at an atomic level (31). 
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Heise et al. also reported an extended β-sheet core in A53T AS fibrils (41). However, this study 
reported encountering problems in reproducing samples yielding different fibril polymorphs 
between different batches of WT sample preparations (42). Therefore, the irreproducible sample 
preparations make it difficult to obtain an accurate structural comparison between the WT and 
A53T mutant fairly. On the other hand, we have reproduced spectrally identical AS fibril 
samples from one batch to the next for the wild-type and mutants (31, 43, 44) that we have used 
here to investigate the anomalies and differences between two of the mutants, E46K and A53T, 
and the WT in the fibril state using SSNMR. 
5.4  Materials and Methods 
5.4.1  Protein sample preparation 
Uniformly-15N, 13C labeled WT, A53T and E46K AS were prepared following previously 
published protocols (43). In summary, recombinant protein expression was performed in E. coli 
BL21(DE3) using minimal media supplemented with BioExpress (Cambridge Isotopes). 
Purification, proceeds in high yield (~60 mg per L), is performed with chemical lysis and two 
chromatographic steps (hydrophobic interaction and gel exclusion). Sample purity was 
confirmed by SDS-PAGE gel electrophoresis and mass spectrometry.  
5.4.2  α-Synuclein fibrillation 
Solutions of monomeric AS (1 mM, 50 mM phosphate buffer, pH 7.5, 0.02% azide, 0.1 mM 
EDTA) were syringe filtered (0.22 µm filters) and seeded with natural abundance pre-generation 
AS fibrils. Samples were then incubated with shaking (200 rpm) at 37 oC as previously described 
(43).  
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5.4.3  Electron microscopy 
A53T, E46K and WT AS fibril samples were treated with Karnovsky’s fixative. After 
negatively staining with 2 % ammonium molybdate (w/v), samples were applied on formvar 
carbon coated grids (300 mesh). Samples were viewed, operating at 75 kV, with a Hitachi H600 
Transmission Electron Microscope. 
5.4.4  α-Synuclein fibril preparation for solid-state NMR experiments 
After 3 weeks of fibrillation, samples were ultracentrifuged for 1 hr at 100,000 g. The 
resultant pellets were washed and re-ultracentrifuged again for 1 hr at 100,000 g. The supernatant 
was removed. AS fibril pellets were dried under a stream of N2 (g) until the final mass was 
unchanged (45). The dried pellets were packed into 3.2 mm (thin or standard wall) NMR rotors 
(Varian, Inc., Palo Alto and Walnut Creek, CA and Fort Collins, CO; now part of Agilent 
Technologies, Santa Clara, CA and Loveland, CO), rehydrated to 36% water by mass and kept 
hydrated by Kel-F and rubber spacers (44). 
5.4.5  Solid-state NMR data collection and analysis 
A 14.1 Tesla (600 MHz, 1H frequency) Varian Infinity Plus spectrometer equipped with a 3.2 
mm T3 Varian BalunTM 1H-13C-15N MAS probe, in triple resonance mode, was utilized to 
perform all E46K SSNMR experiments. A 17.6 Tesla (750 MHz, 1H frequency) Varian Unity 
Inova spectrometer equipped with a Varian 3.2 mm BalunTM 1H-13C-15N MAS probe, in triple 
resonance mode, was utilized to perform all A53T SSNMR experiments. All experiments 
utilized tangent ramped cross polarization (46) and SPINAL-64 (47, 48) 1H decoupling during 
acquisition and evolution periods with ~75 kHz of field strength. For 3D 15N-13C-13C and 13C-
15N-13C correlation experiments, band-selective SPECIFIC CP (49) was employed for 
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heteronuclear polarization transfer between 15N and 13C and DARR (50) mixing for 13C 
homonuclear polarization transfer. All E46K experiments were acquired under 13.3 kHz magic 
angle spinning and at a variable temperature of 10 oC. All A53T experiments were acquired 
under 10.0 kHz magic angle spinning and at a variable temperature of 0 oC. Chemical shifts were 
externally referenced using adamantine; the downfield peak was assumed to resonate at 40.48 
ppm (51).  
Data were processed by applying back linear prediction to the direct dimension. Zero filling, 
Lorentzian-to-Gaussian apodization and/or cosine bells were applied for each dimension before 
Fourier transformation using nmrPipe (52). Peak picking, assignments and peak heights were 
obtained with NMRViewJ software (53) using Gaussian peak integration methods.  
5.5  Results and discussion 
5.5.1  Sample characteristics 
Recombinant protein expression was performed with E. coli BL21(DE3) cells and purified 
yielding ~60 mg of uniformly-15N, 13C labeled WT, A53T and E46K per liter of media (43). 
Monomer samples were set to aggregate and the mutant fibrillation kinetics were confirmed to be 
faster than WT AS (Figure 5.1a), as previously reported by monitoring Thioflavin T fluorescence 
(22, 24, 26-30). Fibrils were also found to have similar fibril morphology using electron 
microscopy (24, 32, 33), as shown in Figure 5.1b. Hydration levels were measured to be 36% 
water by mass as per previously published protocols for each of the samples (38). 13C-13C 2D 
experiments were acquired of each of the mutant fibril samples (Figure 5.1c,d). The spectra 
exhibit narrow linewidths, <0.2 ppm, indicative of well ordered and homogeneity throughout the 
fibrils, as previously observed for the WT (38).  
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5.5.2  De novo chemical shift assignments of the α-synuclein fibril mutants 
De novo chemical shifts were assigned using multidimensional SSNMR experiments for both 
mutant fibrils, listed in Table 5.1. The same amide frequency in three of the spectra—NCACX, 
NCOCX and CAN(co)CX—can be used to make a sequential connection, resulting in site-
specific chemical shift assignments, illustrated in Figure 5.2. The same can be performed using 
the alpha carbon frequency in the NCACX and CAN(co)CX experiments or carbonyl carbon 
frequency in the NCOCX and CAN(co)CX experiments. Sequential assignments for E46K were 
possible from K46-V49, T59-Q79, G84-F94 and G106-P108. Sequential assignments for A53T 
were also possible from S42-V49, V52-V55 and T59-K97. Chemical shift assignments are listed 
in Table 5.2 and 5.3 for E46K and A53T respectively. 
5.5.3  Major chemical shift perturbations upon E46K mutation 
We recently published the secondary structure of the WT, which possesses a repeated β-sheet 
motif: long (L38-V49), short (V52-V55), short (V63-V66), long (G68-Q79), short (T81-G84) 
and short (A89-K97) (44). In the WT secondary structure, E46 is located in the first of the two 
long β-sheet strands. In addition, a major replacement in the side-chain charge of position 46 is 
made upon the E46K mutation: negative to positive. These two factors may cause disruptions in 
salt bridges, electrostatic interactions and hydrogen bonds established in the WT structure upon 
fibrillation. Therefore, it is not surprising that upon mutation, the chemical shift perturbations are 
largely evident across the amino acid sequence, as shown in Figure 5.3.  
Carbon thirteen chemical shifts are highly susceptible to secondary structure making them a 
useful tool for measuring perturbations upon mutation (54-58). A 13C-13C 2D spectrum of E46K 
exhibits major perturbations compared to the WT (Figure 5.3). Correlations corresponding to 
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residues I88 and T92 have shifted downfield, while S87, A89, A90, A91 and G93 have all 
shifted upfield in the E46K spectrum relative to the WT.  
5.5.4  Minor chemical shift perturbations upon A53T mutation 
We find that the perturbations upon the A53T mutation are minor relative to the E46K 
mutation. In the WT secondary structure, A53 is located in the first of the two short β-sheet 
strands, where upon mutation may not cause a major change in secondary structure relative to 
E46K. The Ala region of the A53T AS fibril 13C-13C 2D spectrum overlays nicely with that of 
the WT, of course with the exception of A53, at 50 and 21.5 ppm (Figure 5.4). The mutated Thr 
correlation now is detected at 61.8 (CA), 70.4 (CB) and 173.6 ppm (C’) found in the Thr region 
where perturbations to T54 and T59 are also evident. The CA and N chemical shift differences 
between WT and A53T AS fibrils are found near the mutation site, the 60s and 80s.  
It is interesting to note the differences for the N, C’, CA and CB chemical shifts of residue 
E83: 0.2, 0.0, 0.1 and 1.4 ppm respectively (Figure 5.4). The difference between the E83 CG 
chemical shifts is 1.0 ppm. Figure 5.5 illustrates a possible model describing how the chemical 
shifts corresponding to the CB and CG of E83 can be perturbed more than 1.0 ppm while those 
of the N, C’ and CA are not effected within error.  
5.5.5  Conformational dynamics and secondary structure comparison between the mutants and 
WT 
In addition to chemical shifts, we can also compare the relative rigidity of the fibril core 
using SSNMR. The signal intensity of a dipolar-based CANCO experiment reports on dynamics 
qualitatively, where the higher the signal intensity the more rigid the region in question (59). It is 
not surprising that the region responsible for fibrillation, reported by Giasson et al. as residues 
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71-82 for the WT, exhibits high signal intensity regardless of mutation (Figure 5.6). However, it 
is of note that in the WT and A53T the signal intensity of the 90s are also strong while, this is not 
true for E46K. This suggests that the 90s for the E46K fibril are relatively more dynamic, which 
might suggest some possible differences in the fibrillation pathway.  
Because chemical shifts are highly sensitive to atomic environment (54-58), backbone 
dihedral angles (Φ and Ψ) and secondary structure can be predicted. Chemical shift assignments 
were imputed into the TALOS+ program (57, 60) to obtain the backbone dihedral angels and 
secondary structure for E46K and A53T AS fibrils. E46K exhibits a long β-sheet strand between 
residues K60-Q79 and three short β-sheet strands located at residues G47-V49, G84-A85 and 
A89-G93. This is a large change in secondary structure compared to the WT. This is likely the 
result of changing a negatively charged amino acid, positioned centrally in the WT fibril core, to 
positive. These differences may also be related to the accelerated aggregation rate upon mutation 
to E46K (22). The secondary structure of A53T is similar to the WT secondary structure (44), 
with the exception of the placement of the last β-sheet A91-K97. The small change in amino 
acid—Ala to Thr—may not be enough to disrupt the packing of the fibril; thus minor 
perturbations are observed.  
5.6  Conclusion  
 AS fibrils are the main component of the pathological hallmark of PD, Lewy Bodies. AS is 
further related to PD by the presence of three single point mutations A30P (7), E46K (8) and 
A53T (9). Here, we have compared the secondary structure of E46K and A53T to the WT. Our 
results indicate a similar secondary structure between A53T and WT AS fibrils, with slight 
perturbations near the mutation site, and in the 60s and 80s. We find large chemical shift 
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perturbations upon the E46K mutation and major perturbations in the final fibril secondary 
structure. The level of structural perturbation is in high agreement with our secondary structure 
determined for the WT (44). 
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5.8  Figures 
 
 
Figure 5.1  Carefully controlled in vitro fibrillation conditions provide microscopically well-
ordered mutant AS fibrils that form more rapidly than WT. (a) Average fibril formation assay of 
(blue squares) WT, (orange circles) E46K and (red triangles) A53T AS fibrils monitored by 
Thioflavin T fluorescence. Error bars were determined from seven replicates for each. (b) 
Comparison of the electron micrographs of (top) WT, (middle) E46K and (bottom) A53T AS 
fibrils. 13C-13C 2D with 50 ms DARR mixing of (c) E46K and (d) A53T AS fibrils.  
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Figure 5.2  Multidimensional spectra with high sensitivity and resolution allowed for the 
chemical shift assignments of A53T AS fibrils. (left) Backbone-walk schematic. (right) 
Illustration of backbone connectivity through the NCACX (red), NCOCX (blue) and 
CAN(co)CX (orange) spectra of residues A90-E83 for A53T AS fibrils. All spectra acquired 
with 50 ms DARR mixing acquired at 750 MHz 1H frequency and 12.5 kHz MAS spinning. 
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Figure 5.3  The E46K mutation causes major chemical shift perturbations throughout the AS 
fibril sequence. (left) Expansions of 13C-13C 2D spectral overlays (50 ms DARR mixing, 600 
MHz 1H frequency and 13.3 kHz MAS rate) of WT (blue) and E46K (orange) AS fibril samples. 
(right) Plot of chemical shift perturbations between WT and E46K chemical shifts versus residue 
number. Residues labeled as (*) correspond to perturbations above the y-axis scale. Residues 
labeled as (#) correspond to glycines. The mutation is indicated with (†). Error bars correspond 
to the chemical shift variations from one WT batch to another. WT chemical shift assignments 
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were obtained from the Biological Magnetic Resonance Bank #16939. E46K chemical shift 
assignments were obtained de novo. 
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Figure 5.4  The A53T mutation causes minor perturbations. (left) Expansions of 13C-13C 2D 
spectral overlays (50 ms DARR mixing, 600 MHz 1H frequency and 13.3 kHz MAS rate) of WT 
(blue) and A53T (red) AS fibril samples. (right) Plot of the chemical shift perturbations between 
WT and A53T chemical shifts versus residue number. Residues labeled as (*) correspond to 
perturbations above 1 ppm. Residues labeled as (#) correspond to glycines. The mutation is 
indicated with (†). Error bars correspond to the chemical shift variations from one WT batch to 
another. WT chemical shift assignments were obtained from the Biological Magnetic Resonance 
Bank #16939. A53T chemical shift assignments were obtained de novo. 
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Figure 5.5  A possible model describing the interaction between residues E83 and A53T.
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Figure 5.6  Normalized peak heights from CANCO experiment as a function of residue number 
for (orange) E46K, (red) A53T and WT (blue). Representation of the secondary structure of WT 
AS fibrils based on TALOS+ analysis (β-strands, arrows; turn or loop curved lines; not 
predicted, dashed lines) from Comellas et al. (2011) J. Mol. Biol. 411, 881-895. Region 
responsible for fibrillation highlighted with a black outlined box. Grey boxes highlight WT β-
strands. 
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Figure 5.7  TALOS+ predicted backbone dihedral angles ψ (circles) and φ (squares), error bars 
based on the 10 best TALOS+ database matches as a function of residue number for (a) E46K 
and (b) A53T. Representation of the secondary structure of WT (blue), E46K (orange) and A53T 
(red) AS fibrils based on TALOS+ analysis (β-strands, arrows; turn or loop curved lines; not 
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predicted, dashed lines). Wild-type TALOS+ results based on those from Comellas et al. (2011) 
J. Mol. Biol. 411, 881-895. 
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5.9  Tables 
 
Table 5.1  Description of the 2D and 3D experiments acquired in order to obtain the de novo 13C, 
15N chemical shift assignments for U-13C, 15N E46K and A53T AS fibrils. The total amount of 
protein was calculated based on the intensity of a 13C 1D DP experiment versus that of 
adamantane (the mass for adamantane was determined before packing the sample in the rotor).  
 
Mutant Experiments Dimensions acquired 
Instrument 
(1H frequency) 
Mixing time 
and sequence 
Acquisition 
Time (hrs) 
Amount of 
sample 
(mg) 
E46K CC 2D 600 MHz 50 ms DARR 9.5 ~23 
E46K N(CA)CX 2D 600 MHz 50 ms DARR 22 ~14 
E46K NCACX 3D 600 MHz 50 ms DARR 87 ~14 
E46K N(CO)CX 2D 600 MHz 50 ms DARR 2 ~14 
E46K NCOCX 3D 600 MHz 50 ms DARR 100 ~14 
E46K CA(NCO)CX 2D 600 MHz 50 ms DARR 28 ~23 
E46K CANCO 3D 600 MHz ---- 126 ~23 
E46K CAN(CO)CA 3D 600 MHz R2T 251 ~23 
E46K CAN(CO)CX 3D 600 MHz 50 ms DARR 263 ~23 
A53T CC 2D 600 MHz 50 ms DARR 9 ~20 
A53T CC 2D 750 MHz 50 ms DARR 32 ~20 
A53T N(CA)CX 2D 750 MHz 50 ms DARR 2.3 ~20 
A53T NCACX 3D 750 MHz 50 ms DARR 54 ~20 
A53T NCOCX 3D 750 MHz 50 ms DARR 40 ~20 
A53T CA(NCO)CX 2D 750 MHz 50 ms DARR 3 ~20 
A53T CANCO 3D 750 MHz ---- 33 ~20 
A53T CAN(CO)CX 3D 750 MHz 50 ms DARR 110 ~20 
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Table 5.2  13C and 15N chemical shift assignments of E46K AS fibrils (with 36% water by mass) 
using only uniformly labeled samples. Mutation designated by (*). 
 
Residue 15N 13C’ 13CA 13CB 13CG 13CD 13CE 
K46* 127.8 173.3 52.5       42.2 
G47 111.8 172.8 45.8         
V48 118.1 175.8 60.6 36.1 22.6/21.4     
V49 126.4 172.2 62.7   21.4     
H50 129.9             
T59   173.8 62.0 69.2       
K60 126.1 174.4 54.0 33.1     44.0 
E61 121.0 174.0 54.9 34.2 36.8 179.8   
Q62 124.1 174.4 54.5 34.1 34.3 177.0   
V63 130.5 174.8 61.2 34.8 22.8/20.9     
T64 122.9 173.7 62.5 71.3 21.4     
N65 128.6 172.9 52.8 42.5 175.5     
V66 124.4 174.1 59.7 35.9 20.4/19.4     
G67 111.6 172.2 44.5         
G68 109.7 170.8 44.6         
A69 124.5 174.9 49.6 25.0       
V70 122.8 174.6 61.1 34.1 21.3/20.2     
V71 127.3 175.8 61.2 34.9 23.0/21.9     
T72 119.7 175.3 60.7 69.3 22.9     
G73 107.6 172.0 44.2         
V74 123.0 174.5 61.2 34.8 22.2/21.2     
T75 124.7 171.8 61.5 71.3 20.4     
A76 129.6 175.8 49.6 23.2       
V77 120.6 172.8 60.0 35.6 22.4/20.3     
A78 130.4 175.7 49.4 23.3       
Q79 119.4 175.5 52.3 33.0 177.7 177.6   
G84 131.1 173.0 42.8         
A85 127.1 175.2 50.1         
G86 116.4 174.4 46.7         
S87 116.5 173.1 59.4 64.5       
I88 122.6 174.9 61.4 40.3 27.2/17.9 13.3   
A89 127.0   50.1 23.3       
A90 124.5 175.0 52.1 18.0 17.9     
A91 125.2 175.8 49.9 23.3       
T92 121.8 174.8 61.4 71.4 21.5     
G93 115.0 170.3 47.3         
F94 114.9   54.5         
G106 104.3 172.2 43.5         
A107 117.3 176.9 55.5 18.8       
P108 118.5   61.4   27.0 52.8   
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Table 5.3  13C and 15N chemical shift assignments of A53T AS fibrils (with 36% water by mass) 
using only uniformly labeled samples. Mutation designated by (*). 
 
Residue 15N 13C’ 13CA 13CB 13CG 13CD 13CE 15NE 
S42 111.9 171.4 58.8 67.6         
K43 122.7 175.9 54.9 36.3  - -  46.0 -  
T44 113.9 175.3 59.8 71.6 22.6       
K45 123.0 173.8 56.5 37.0 27.3  - -  -  
E46 126.6 175.0 54.2 32.6 35.3 183.1     
G47 115.7 172.9 48.6           
V48 118.9 174.4 59.8 37.9 24.2/21.0       
V49 126.7 -  61.7 34.2 -        
V52  - 174.4 61.3 34.1 20.9       
    T53* 127.8 173.6 61.8 70.4 21.5       
T54 126.9 172.7 61.7 70.4 21.4       
V55 128.4  - 62.1 -  -        
T59 122.4 176.5 67.3 67.3 22.9       
Q62  - 173.9 54.6  -  -     -  
V63 126.5 174.5 61.4 34.1 21.4       
T64 126.8 172.7 62.5 69.7 22.0       
N65 125.4 172.9 52.1 43.8 175.1     -  
V66 127.5 177.8 60.9 33.8 21.6       
G67 111.5 172.6 46.8           
G68 103.6 172.5 43.5           
A69 126.8 175.5 50.5 23.5         
V70 120.9 174.7 60.2 36.0 21.6       
V71 126.6 176.5 61.3 35.4 21.1       
T72 115.7 175.7 59.7 69.7 22.3       
G73 109.6 173.2 44.3           
V74 123.8 175.2 61.6 35.1 21.2/19.6       
T75 128.0 172.3 62.1 70.5 21.6       
A76 130.6 174.4 50.0 21.5         
V77 124.1 173.0 60.9 36.1 21.5/20.6       
A78 130.3 176.3 50.1 25.1         
Q79 120.5 176.7 52.6 33.1 33.8 177.7   111.3 
K80 123.1 176.1 60.6 32.5 26.9 31.6 42.4 -  
T81 113.7 173.7 61.4 72.4 22.7       
V82 126.4 174.8 61.8 34.2 20.5       
E83 126.4 175.3 54.0 33.9 36.2 183.2     
G84 113.0 173.7 45.3           
A85 131.0 179.0 53.5 18.7         
G86 111.0 174.1 46.8           
S87 116.2 173.6 59.1 65.0         
I88 121.7 175.6 60.4 40.6 27.6/17.7 13.6     
A89 129.7 177.1 55.2 18.9         
A90 123.1 174.8 51.5 21.2         
A91 127.7 175.7 49.9 23.3         
T92 125.6 174.8 61.3 70.2 22.0       
G93 115.1 170.3 47.7           
F94 126.7 173.8 54.8 46.0  -  - -    
V95 128.1 171.6 61.4 35.1 22.3/20.8       
K96 133.3 173.3 55.2 38.3 26.0 31.3 42.0 -  
K97 130.5 175.1 54.3 34.3 25.3 30.8 42.3 -  
D98 124.2 175.2 55.1 42.7         
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CHAPTER 6 
FIBRILS FORMED UNDER ACIDIC CONDITIONS 
6.1  Notes and Acknowledgements 
I would like to thank Dr. Trent Franks, Dr. Heather Frericks Schmidt and Dr. Lindsay 
Sperling for helpful discussions about data collection and analysis. 
6.2  Abstract 
Mitochondrial deficiencies and oxidative stress caused by cytosolic acidification have been 
associated with Parkinson’s disease patients. This evidence motivates the isolation of differences 
between physiological and low pH α-synuclein (AS) fibrils. Here we have used the advantages 
of solid-state NMR to illustrate such differences and our results illustrate an overall perturbation 
to the fibril secondary structure. In particular, the chemical shifts that correspond to side-chain 
carboxyl groups shifted upfield; this was consistent with a decrease in pH causing the 
protonation of these side-chains. Investigating how the fibril structure is perturbed upon 
decreasing pH can provide insight into the driving force of fibril stability. 
6.3  Introduction 
Parkinson’s disease (PD), multiple system atrophy and many other neurodegenerative 
diseases have shown similar pathologies including filamentous inclusions termed Lewy bodies 
(1). The principal proteinaceous component of Lewy bodies is aggregated α-synuclein (AS), a 
natively unfolded, 140 residue protein (2). Mutations in the AS gene (A30P, E46K and A53T) 
have been found to lead to the familial form of PD (3-5). Protein fibrils, such as AS, are 
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predominantly composed of a β-sheet secondary structure. Initially, AS forms a prefibrillar 
intermediate termed protofibrils, which further assemble into mature fibrils (6). The detailed 
mechanism of how AS fibrils assemble—from monomers through protofibrils to mature fibrils—
is poorly understood. The toxic state of AS, whether it is the protofibrils or the mature fibrils, 
and how the mechanism relates to PD, is an ongoing debate (7-9). Structural information on 
fibrils could facilitate answering these questions.  
Different factors have been shown to significantly affect the rate of fibrillation in vitro, such 
as metals (10), oxidation (11), phosphorylation (12) and nitration (13, 14). In particular, lowering 
the pH the monomer solution causes the rate of fibrillation to increase (15). A useful 
consequence of this property is that reduced pH may be used to decrease sample preparation 
times; however, whether the structure remains the same at an atomic level requires further 
investigation. Decreasing pH may also cause residues with carboxylic acid side chains to become 
protonated. This would principally affect the C-terminus (96-140), which is predominantly 
composed of acidic residues (Figure 6.1). The C-terminus, in neutral pH samples, is charged and 
inhibits fibril aggregation (16-18); in addition, it is proposed to be unfolded in the fibril state. 
Recently, mitochondrial deficiencies (19-21) and oxidative stress caused by cytosolic 
acidification have been associated with PD cases (22). This evidence motivates the isolation of 
differences between physiological and low pH AS fibrils. In addition, this can provide insight 
into the driving force of fibril stability.  
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6.4  Results and discussion 
6.4.1  Behavioral and physical differences between pH 5.0 and pH 7.5 AS fibrils  
Experiments were performed at pH 5.0 to take advantage of the increase in fibrillation rate at 
a decreased pH (Figure 6.2) (15). In addition to an increased fibrillation rate, other physical 
properties of pH 5.0 fibrils were determined. At pH 7.5, the AS monomer required a minimum of 
10 days of shaking at 37 oC to fully form fibrils. In contrast, at pH 5.0, the monomer only 
required 48 h. By visual inspection, fully formed pH 7.5 fibrils consisted of a highly viscous, 
clear gelatinous substance, where pH 5.0 fibrils appeared as an opaque white precipitate in 
solution (Figure 7.3). The end products were identical by visual inspection after drying (Figure 
6.4); nonetheless, both had different properties. By decreasing the pH of the solution, the C-
terminus became more protonated as the pH approached the pKa, 4.8, of the carboxyl side-chain 
groups. We hypothesize that making the C-terminus more hydrophobic will result in an attraction 
towards the N-terminus and drive the increase of fibril formation into a different structure. 
6.4.2  Solid-state NMR spectral comparison of AS fibrils at pH 5.0 versus pH 7.5 
One-dimensional (1D) 13C-detected direct-polarization (DP) magic-angle spinning (MAS) 
solid-state NMR (SSNMR) spectra of both uniformly-13C, 15N labeled AS fibril samples were 
acquired for comparison (Figure 6.5). The pH 5.0 fibril spectra have similar chemical shift 
characteristics to pH 7.5 fibrils; however, slight differences are evident throughout the spectra. 
Spectral differences are evident through chemical shift changes and the presence or absence of 
certain peaks in the spectra. The slight upfield shift of the acidic residue side chain correlations 
are due to the protonation of those sites. When pH is decreased close to the pKa of carboxyl 
groups, acidic residue side chains gain a proton on the highly electron dense oxygen, and 
therefore, electron density is decreased. Consequentially, the carbonyl carbon became more 
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shielded resulting in a more upfield carbon chemical shift. In AS, the majority of glutamates and 
aspartates are located in the C-terminus (Figure 6.1). Thus, the side-chain carbonyl cross peaks 
were shifted in the pH 5.0 spectrum. Nevertheless, the resolution present in the 1D spectra is not 
adequate to obtain any site-specific information. 
For an initial comparison, several 13C-13C and 15N-13C 2D correlation experiments were 
acquired on pH 5.0 and pH 7.5 fibrils varying in DARR (23) mixing times from 10 to 250 ms. 
Shorter mixing times, i.e., 10 ms, primarily result in intra-residue correlations between one or 
two bonds observed in the spectrum. In the case of longer mixing times, the polarization travels 
further resulting in longer-range correlations in the spectra. Differences between the two fibril 
preparations were observed in the 13C-13C 2D spectra with 50 ms DARR mixing (Figure 6.6c, d). 
Side-chain carbonyl cross peaks appear to shift upfield overlapping a highly congested region in 
the pH 5.0 fibril spectrum compared to the pH 7.5 fibril spectrum (Figure 6.6a, b), as a result of 
protonation of these sites. In addition, the pH 5.0 alanine region (Figure 6.2f) displays an outlier 
peak at 53 and 16 ppm not found in comparable pH 7.5 fibril spectra at 0 oC. However, spectra 
acquired of pH 7.5 fibrils at lower temperatures exhibit the outlier peak (24). As temperature is 
decreased, rigid regions become more CP efficient, demonstrating this residue is mobile in pH 
7.5 fibrils compared to pH 5.0 fibrils. Furthermore (Figure 6.2e), both isoleucine spin systems 
are prominent in the spectrum of pH 5.0 fibrils compared to the pH 7.5 fibril spectrum. 
Conversely, the second isoleucine spin system, Ile 112, appears in more advanced experiments, 
such as TEDOR (25) for pH 7.5 fibrils, where polarization transfer is less dependent on 
dynamics. This points towards a rigid Ile 112 in the pH 5.0 fibrils relative to the pH 7.5 fibrils. 
These spectral changes may be attributed to the increased propensity of the C-terminus to self-
associate at pH 5.0, where a larger population of the acidic residue side-chains are protonated. 
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This observation further validates the possible role of the C-terminus inhibiting fibril formation 
in pH 7.5 fibrils (17, 18, 26). 
6.4.3  Rigidity in low pH AS fibrils 
Another SSNMR experiment that provides information on structural differences is the 
constant-time J-based experiments (27, 28). The previous dipolar-based experiments, involved 
polarization transfers occurring through space, which produce both intra- and inter-residue 
correlations. Constant-time, J-based homonuclear experiments utilize polarization transfer 
through scalar couplings (or through bond) solely producing correlations from single bond 
transfers. This produced a highly resolved spectrum, which had fewer correlations and allows for 
a simplified analysis. Therefore, constant-time uniform-sign cross-peak (CTUC) correlation 
spectroscopy (COSY) spectra of both fibril types, optimized for both the aliphatic (Figure 6.7b) 
and CA-CO correlations, (Figure 6.7a) were acquired.  
An additional advantage to the CA-CO optimized spectrum is that it resolves correlations of 
the carbonyl side chains of acidic residues, which in turn provide more detailed information 
about the protonation state of these carbonyl side chains. The spectra of pH 7.5 fibrils were 
acquired with cross polarization (CP) (29), producing cross peaks from more rigid regions. The 
pH 5.0 fibril spectra were acquired with direct polarization (DP), producing cross peaks for the 
more dynamic regions. Ideally, increasing sample temperature increases the motion of dynamic 
regions and improves polarization transfer through random coil regions in DP experiments. 
Conversely, decreasing the temperature of CP experiments would increase polarization transfer 
through rigid regions, such as β-sheets and the fibril core of AS. Similar to the side-chain 
carbonyl region of the 13C-13C 2D spectra (Figure 6.6a), upfield shifted pH 5.0 fibril cross peaks 
are found in the CA-CO optimized CTUC COSY spectra (Figure 6.7a). Although better resolved, 
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a fair comparison between the pH 5.0 fibril spectrum and the pH 7.5 spectrums could not be 
reached due to the differences in acquisition technique (i.e., DP versus CP). For example, the 
outlier peaks between ~60-50 ppm (Figure 6.7a) in the indirect dimension, characteristic of 
acidic CA chemical shifts, maybe attributed to the protonation of the C-terminus or regions of 
pH 5.0 fibrils having different dynamic properties. This, when combined with the other apparent 
differences, may indicate an overall structural difference of the pH 5.0 fibril and not just the C-
terminus. Acquiring a DP spectrum of the pH 7.5 fibrils and a CP spectrum of the pH 5.0 fibrils 
can aid in defining the differences between the rigid and dynamic regions of the fibril. 
Similar differences are seen in the aliphatic optimized CTUC COSY spectrum (Figure 6.6b). 
The pH 5.0 fibrils were acquired with DP (red) and CP (green) both at 0 oC, while the pH 7.5 
fibrils were acquired with CP (blue). The DP spectrum of pH 5.0 fibrils was useful in resolving 
13 new cross peaks (per side of the diagonal) in the methyl region, which contains glutamate and 
lysine side chain correlations (Figure 6.7c). The resonance at 30 ppm in the direct and 35 ppm in 
the indirect dimension is consistent with the chemical shifts of Glu Cγ-Cδ. In the pH 5.0 fibril 
spectrum this cross peak shifted slightly upfield in the indirect dimension compared to the same 
resonance in the pH 7.5 fibril spectrum. This is similar to the spectral differences found in the 
CA-CO optimized spectra (Figure 6.7a) and the 13C-13C 2D spectra for the carbonyl side chain 
regions (Figure 6.6a, b). The above-mentioned outlier peak, found in the alanine region of the 
13C-13C 2D spectrum (Figure 6.6f), appears in the CP spectrum and not in the DP spectrum 
(Figure 6.7d) of the pH 5.0 fibril CTUC COSY experiments, which further confirms this residue 
is in a rigid part of the pH 5.0 fibril in contrast to the pH 7.5 fibril. Familiarization of how 
protonation affects regions of the fibril, by comparing site-specific information, could help 
understand the driving force of fibril formation. A more detailed comparison of the two fibril 
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preparations would be possible if the spectra were acquired with similar conditions, such as with 
the same hardware, temperature, pulse sequence, decoupling power and acquisition time. 
6.4.4  Assigning low pH AS fibril chemical shifts site-specifically 
13C-13C 2D spectra provide abundant information, including amino acid type and assignments. 
However, site-specific amino acid assignments are necessary to fully understand the structural 
differences between the two types of fibril preparations. Moving to further dimensions, such as 
NCACX and NCOCX three-dimensional (3D) spectra (Figure 6.8b, c), can be used to assign 
site-specific chemical shifts. These experiments possess a common 15N frequency relating two 
adjacent residues, i.e., the i and i±1 residue (Figure 6.8a). Because 15N chemical shifts are highly 
dependent on solvent conditions, rigid regions of the fibril not affected by pH would display 
similarities in 13C frequencies and differences in 15N frequencies. However, differences can be 
observed in both 15N frequencies and 13C frequencies (Table 6.1). The residue side-chains 
exposed to solvent are more likely to experience an environmental change causing changes in 
chemical shifts. Being that the variations between the chemical shifts are primarily present in the 
fibril core; thus, differences in the homogeneity of the fibril core are likely.  
6.4.5  Chemical shift differences between low pH and pH 7.5 
The majority of the fibril core backbone chemical shift assignments for pH 7.5 fibrils are 
confirmed; however, the majority of pH 5.0 fibrils are tentatively assigned (Table 6.1). 
Assuming all assignments are confirmed in both types, ~30% of the chemical shifts coincide 
with both fibril types and ~70% of those are different within ± 0.6 ppm, Figure 6.8. Further 
analysis of current data sets is needed to confirm assignments and make a fair comparison 
between pH 5.0 and pH 7.5 fibrils. However, even in the NCC 3D experiments there are highly 
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degenerate planes, where foreseeable ambiguity will hinder the chemical shift assigning process. 
Therefore, acquiring experiments with higher resolution (further dimensions) and higher 
sensitivity (improved pulse sequences) will aid in identifying site-specific assignments and 
differences between the two types of fibrils. 
6.4.6  Possible future experiments 
We have observed noteworthy physical property and spectral differences between pH 5.0 and 
pH 7.5 fibrils. However, the SSNMR experiments acquired have only provided some site-
specific information due to congestion in numerous planes, similar to other proteins studied by 
SSNMR (30, 31). Using an additional dimension (CNCC 4D) (32) has shown promising results 
by increasing resolution and facilitating site-specific assignments. Nevertheless, when DARR 
(23) based experiments are used, the polarization transfer efficiency from one 13C resonance to 
another can be 10% or less, making multidimensional experiments extremely difficult. The 
application of rotational resonance tickling (R2T) (33) or super-cycled POST-C5 (SPC-5) (34) 
have both shown to increase the homonuclear polarization transfer efficiency to 50%. By 
increasing the polarization transfer efficiency, sensitivity is increased and acquisition times are 
reduced. These experiments also decrease ambiguity by eliminating long-range interresidue 
correlations, which appear in longer mixing DARR experiments (23). A 4D CANCOCA 
spectrum using R2T and a 4D CONCACB spectrum using SPC-5 of fibrils at both pH values will 
aid in the progress of site-specific assignments, ultimately facilitating a more detailed structural 
comparison between the two fibril preparations. 
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6.5  Conclusion 
The number of neurodegenerative disease cases is steadily increasing, while the cause of 
such diseases is still not well understood. Furthermore, the toxic state of AS is not well defined 
(7-9). We anticipate that an atomic resolution structural understanding of low pH AS fibrils in 
comparison to physiological pH AS fibrils may lead to important insights into the mechanism of 
AS fibrillation and the development of new PD therapies. 
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6.7  Figures 
 
 
 
Figure 6.1  Sequence of wild-type AS. Residues with negatively charged side chains (at pH 7) 
are highlighted in red, the GxxxG region is highlighted in blue and the KTKEGV imperfect 
repeats are underlined in black. 
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Figure 6.2  AS fibrils form faster at lower pH. Comparison of pH 5.0 (blue circles) versus pH 
7.5 (black squares) fibrillation rates monitored by Thioflavin T fluorescence. 
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Figure 6.3  Low pH AS fibrils are different than pH 7.5 fibrils by visual inspection before 
drying. A photograph of pH 7.5 fibrils after aggregation (a), after ultracentrifugation (b) and pH 
5.0 fibrils before ultracentrifugation (c). 
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Figure 6.4  Low pH AS fibrils are similar to pH 7.5 fibrils by visual inspection after drying. A 
photograph of pH 7.5 fibrils (a) and pH 5.0 fibrils (b) after drying under a stream of nitrogen gas. 
 
  
(a)   (b) 
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13C Chemical Shifts 
 
Figure 6.5  13C 1D spectral comparison of pH 5.0 versus pH 7.5 fibrils illustrates differences 
throughout the spectra. One-dimensional (1D) 13C-detected direct-polarization (DP) spectra of 
WT AS (pH 5.0) spinning at 20.08 kHz MAS (red) overlaid over pH 7.5 spinning at 13.33 kHz 
MAS (blue). Both samples were ~10 mg and were acquired at 0 oC on a 600 MHz 1H frequency 
spectrometer. 
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Figure 6.6  13C-13C 2D spectral comparison of WT AS (pH 7.5 fibrils, blue) with 50 ms DARR 
mixing (11 mg, 1.5 hrs, -10 oC, 500 MHz 1H frequency, 11.111 kHz MAS) versus pH 5.0 WT 
AS (red) (10 mg, 2.5 hrs, 0 oC, 600 MHz 1H frequency, 13.333 kHz MAS). The acidic residue 
side carbonyl region (a, b), Ile CD region (e), and Ala CA-CB region (f) are shown as expansions 
of the carbonyl (c) and aliphatic (d) regions.  
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Figure 6.7  CTUC COSY spectra optimized for the CA-CO (a) and aliphatic correlations (b) of 
WT AS at pH 5.0 with DP (red) and with CP (green) (τ = 3.6 ms, 600 MHz 1H frequency, 25 h, 
20.83 kHz, 0 oC) overlaid with pH 7.5 (cross polarization, τ = 4.5 ms, 500 MHz 1H frequency, 17 
h, 22.22 kHz spinning, 10 oC) (blue). Expansions of the methyl region (c) and the alanine region 
(d) are also shown. The lack of signal in the threonine CA-CB regions is due to a shorter τ value 
used in the pH 5.0 fibril spectra, where the scalar transfer is not as optimal. 
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Figure 6.8  Schematic of backbone walk in NCACX and NCOCX 3D experiments (a). A 
selected plain from both the NCACX (b) and NCACX (c) 3D experiments acquired on pH 7.5 
(600 MHz 1H frequency, 74 h, 0 oC, 50 ms DARR mixing) (blue) and pH 5.0 (500 MHz 1H 
frequency, 60 h, -50 oC, 18 ms DARR mixing) (red) AS fibrils. 
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Figure 6.9  Chemical shift perturbations found throughout the AS sequence when comparing 
low pH to pH 7.5 AS fibrils. CA (green) and CB (purple) chemical shift differences between low 
pH and pH 7.5 plotted versus residue number. 
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6.8  Tables 
Table 6.1  AS pH 5.0 fibril de novo chemical shift assignments (ppm). Residues in italics 
represent low confidence in assignments.  
  15N 13C’ 13CA 13CB 13CG1 13CG2 13CD 13CE 
A27 125.4   51.1 21.4         
E28 115.1 174.1 57.3 30.6         
A29 128.4   49.4 22.5         
A30 126.7 173.7 49.3 25.3         
G31 108.7 171.5 44.9           
K32 121.7 56.6         30.5 41.5 
V40 123.4 175.5 56.5 34.6         
G41 107.3   44.2           
S42 110.6 173.1 58.2 67.1         
K43 120.3   53.8 33.5         
H50 124.8   50.8 31.7         
V52   174.7   32.9 21.1 20.2     
A53 127.5 174.6 49.8 21.4         
T54 110.5 173.1 58.1 71   22.1     
V55     57.8 36.7         
A56 121 174.8 54.4 17.6         
T59 121.1   61.1 70.9         
T64 125.4   61.9 69.6         
N65 125.1   51.6 42.5         
V66 116.5 177 58.4 32         
G67     45.9           
G68 100.3   43.1           
A69     50.2 23.6         
V70     59.6           
T72 117.7   59.6 69.5         
G73     45.2           
V74     62 35.1 22.6 21.3     
T75 127.5   61 70.4         
A76 130   49.8 21.3         
V77 124.5   60.8 35.7         
A78 127   49.9 24.9         
Q79 119.1   53.2 32.4 35.2   178   
K80 123.3   54.1 32.1         
T81 123.2   59.7 71.8         
V82 123.6   60           
E83 126.4   53.8 32.5 33.2   178.2   
G84 104.2 174 44.9           
A85 129.7   50.5           
G86 110.9   47.7           
S87 110.9   56.1           
I88 121.7   58.9 40.8 27.1 17.7     
A89     54.5 18.5         
A90 122.5   50.7 20.8         
A91 125.5   49.6 22.4         
T92 124.8   60.8 69.7         
G93     47.2           
F94     54.5 45.8         
V95 123.3   61.4 34.9         
D98 114.1   54.9 38.4         
L100 125.8   51.5 42.2         
G101 106.1 172.3 43.8           
K102 124.3   54.3 32.4 25.5       
G111 105   46.2           
I112 117.7   59.6 42.6         
D119 134   55.1           
E130 114.2   54.9 32.3     180.7   
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CHAPTER 7 
THE EFFECT OF METALS ON α-SYNUCLEIN FIBRILLATION 
7.1  Notes and acknowledgements 
I would like to thank Professor Chad Rienstra for help with data acquisition and Professor 
Julia George for helpful discussions. 
7.2  Abstract 
α-Synuclein (AS) fibrils are the main component of Lewy bodies, which are indicative of 
Parkinson’s disease (PD) pathology. Although there is no direct evidence linking metals to 
neurodegenerative diseases, elevated levels of metals are found in both healthy aging brain and 
brain of patients with neurodegenerative diseases. However, the rate of AS fibrillation increases 
in the presence of certain metal ions, such as Cu+2 (1, 2), suggesting that metals catalyze in PD 
susceptible patients. Identifying the region where metals cause conformational changes to the 
fibril structure may help reveal the role metals play in neurodegenerative diseases, such as PD. 
7.3  Introduction 
The rate of α-synuclein (AS) fibrillation increases in the presence of certain metal ions, such as 
Cu+2 and Fe+3 (1, 2). In particular, Cu+2 has a significantly high binding affinity to AS (2). The 
induction of nucleation by various metals including Cu+2 has been proposed as an effect of 
neutralizing the repulsion by the negatively charged amino acids primarily in the C-terminus, 
causing the unstructured protein to collapse (1, 3). However, a truncation of the C-terminus has 
shown high affinity Cu+2 binding at the N-terminus (residues 3-9 and 49-52, containing H50) in 
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solution (2). Further evidence has been found indicating that each Cu+2 binding-site is 
independent from each other with no effect on binding affinity upon mutation of residue 50 from 
His to Ala (4). Currently, the AS monomer bound and unbound to Cu+2 has been established to 
have a similar morphology through electron paramagnetic resonance, circular dichroism and 
solution NMR (1, 5). However, these techniques lack the ability to evaluate site-specific 
structural differences between AS bound and unbound to Cu+2 in the fibril state. Although there 
is no direct evidence linking metals to neurodegenerative diseases, evidence of elevated metal 
levels are found in healthy aging brain and in brain of patients with neurodegenerative diseases 
(6), such as Fe+3 (7, 8), Zn+2 (9) and Cu+2 (10). Identifying the region where metals cause 
conformational changes to the fibril structure may help reveal the role metals play in 
neurodegenerative diseases, such as Parkinson’s disease (PD).  
7.4  Proposed project methodology 
To investigate the effects of certain metals on AS fibrils, two types of preparations will be 
utilized. Water is routinely used to remove salt; however, the control samples will utilize a metal 
solution to identify any non-specific interactions, which can lead to false positives. Second, Cu2+ 
and Fe3+ will be added to WT AS monomer solutions before starting the fibrillation process. 
Another consideration should be that Cu2+ and Fe3+ are both paramagnetic, which may cause 
short T2 relaxation (11, 12) and hyperfine shifts (12, 13). Zn2+ is commonly used to substitute or 
dilute paramagnetic ions to reduce these effects (14, 15). In addition, Zn2+ is known to bind AS 
without perturbing the fibrillation kinetics (1) and may serve as a positive control. Short T2 
relaxation results in extreme line broadening for amino acids near the mental center, making 
them difficult to assign. Washing paramagnetic samples with EDTA will remove excess amounts 
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of unbound metal, therefore, reducing the paramagnetic relaxation effect. In addition, analyzing 
the effects of Zn2+ can facilitate the identification of amino acids corresponding to hyperfine 
shifts. 
7.5  Preliminary results 
7.5.1  Sample characterization 
Uniformly 13C, 15N labeled wild-type AS samples were expressed and purified as per 
previously established protocols (16). Two samples were prepared: AS washed with a 10:1 (1) 
ZnCl2: AS and (2) CuCl2: AS molar ratio. While the zinc washed samples did not appear 
different from samples not washed by zinc by visual inspection, the copper washed sample 
exhibited a bluish-green color. Both samples were packed in 3.2-mm rotors and evaluated on a 
600 MHz 1H frequency spectrometer. 
7.5.2  Differences found after exposing α-synuclein fibrils to copper 
Although the 13C1D spectra of both samples exhibited narrow line widths, the copper sample 
possessed a tuning profile indicative of a salty sample, also known as the “bow-tie” effect. 
Therefore, more advanced experiments could not be conducted due to this limitation. Differences 
in peak height are evident in the CA, CB and side-chain carbonyl regions, as shown in Figure 
7.1. The decrease in signal intensity of the side-chain carbonyl regions is likely due to binding of 
the positively charged copper cations to the negatively charged side-chain carbonyl carbons 
primarily found in the C-terminus. This is not surprising because it is well established that the C-
terminus is mobile and free from the fibril core. However, deviations in the other regions of the 
spectrum are likely caused by an interaction between the copper and the protein. 
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7.5.3  Differences found after exposing α-synuclein fibrils to zinc 
Certain amino acids (Gly, Ala, Thr, Ser, Ile, and Pro) are distinctively identifiable in two-
dimensional (2D) spectra by their unique chemical shift patterns and their corresponding 
chemical shifts are further dispersed by secondary structure (17-21). Therefore, to effectively 
compare the standard AS fibril samples to those prepared with metals, 13C-13C 2D spectra with 
50 ms DARR (22) mixing were acquired to identify differences in individual amino acids and 
adjacent residues, eluding to structural differences. The Zn+2 sample displayed a stable tuning 
profile; therefore, acquisition of multidimensional experiments on this sample was possible. The 
Zn+2 sample exhibits three additional Ala residues, as shown in Figure 8.2a. No major 
differences were seen in the Gly region (Figure 7.2b). However, the Thr regions exhibit the 
emergence of five new correlations in addition to a possible Ser correlation (Figure 7.2c, d). 
These results suggest a stabilization of the N-terminal domain of the fibrils. 
7.6  Future direction 
The chemical shift differences between AS and metals (e.g., Cu2+ and Fe3+) (1, 2) can be 
assessed with samples where the addition of metals are added before and after AS fibril 
formation. After samples are prepared, three-dimensional experiments should be acquired on 
each sample to obtain chemical shift assignments. Chemical shifts can then be compared to those 
of standard AS fibrils to identify where these metals are binding. The chemical shift information 
can be further used to empirically determine the secondary structure for each of the samples. 
These results will lead to site-specific knowledge, which may aid in a fundamental understanding 
of fibril formation relevant to PD. 
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7.8  Figures 
 
 
Figure 7.1  Differences found after washing α-synuclein fibrils with copper. 13C 1D spectra of 
α-synuclein fibrils with (green) and without (black) washing with copper. 
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Figure 7.2  Perturbations after washing α-synuclein fibrils with Zn+2. Expanded fingerprint 
regions, Ala CA-CB (a), Gly CO-CA (b), Thr CB-CA (c) and CB-CG (d) in 13C-13C 2D spectra 
of AS fibrils washed with zinc (red) overlaid with standard AS fibrils (blue). All spectra were 
acquired with 50 ms DARR mixing, at 10 oC, on a 600 MHz (1H frequency) spectrometer and 
processed with 0.2 ppm of line broadening. 
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